











A thesis  
presented to the University of Waterloo  
in fulfilment of the  
thesis requirement for the degree of  







Waterloo, Ontario, Canada, 2013 





I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, 
including any required final revisions, as accepted by my examiners. 
 






















     Purpose 
To investigate the impact of cigarrete smoking in a group of otherwise healthy young 
individuals on: 
 1) Retinal blood flow using Doppler based SD-OCT, 
 2) Retinal vascular reactivity using a gas sequencer to provoke hypercapnia via constant 
changes in PETCO2 (end-tidal partial pressure of CO2) and in PETO2 (end-tidal partial 
pressure of O2). 
 
Methods 
An automated gas flow controller was used to achieve normoxic hypercapnia in ten non-
smokers (mean age 28.9 yrs, SD 4.58) and nine smokers (mean age 27.55 yrs, SD 4.77). 
Retinal blood flow measurements were obtained using Doppler OCT and cannon laser 
blood flowmeter (CLBF) during baseline, normoxic hypercapnia (15% increase in PETCO2 
relative to homeostatic baseline) and post-hypercapnia in both the groups. Exhaled carbon 
monoxide level was measured in all subjects. 
 
Results 
In non-smokers, retinal arteriolar diameter, blood velocity and flow increased by +4.1% 
(SD 2.8, p<0.0001), +16.7% (SD 14.6, p=0.0004) and +29.6% (SD 12.5, p<0.0001) 
respectively, during normoxic hypercapnia; Similarly,  the venous area, venous velocity 




p=0.0068) and 26% (SD 22.9, p<0.0001) respectively. In smokers, normoxic hypercapnia 
resulted in a significant increase in velocity by 12.0% (SD 6.2, p=0.0019) and flow by 
14.6% (SD 9.5, p=0.0029); though arteriolar diameter increased by 1.7% (SD 1.7, 
p=0.2616), the result was not statistically significant. Total retinal blood flow increased 
significantly by 19.3% (SD 18.4, p=0.002) in response to normoxic hypercapnia. However, 
there was no significant difference in venous area (p=0.3322) and venous velocity 
measurements (p=0.1185) during hypercapnia compared to baseline and recovery. 
Comparing smokers and non-smokers, only the percentage change in arteriolar diameter 
(p=0.0379) and flow (p=0.0101) was significantly different among the groups. Group mean 
PETCO2 was increased by 15.9% in the non-smoking group and by 15.7% in the smoking 
group, with a concomitant increase in PETO2 by approximately 1.5 to 2% in both groups. 




Retinal vascular reactivity in response to normoxic hypercapnia is significantly reduced in 
young healthy individuals who smoke compared to non-smokers. Further studies are 
needed to elucidate the exact reason behind the impaired retinal autoregulation to 
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1 Introduction  
Blood supply to the human retina is derived from two distinct vasculatures namely: the 
central retinal artery and the choroidal vessels. The central retinal artery supplies the inner 
two-third of the retina whereas the outer retina including the retinal pigment epithelium 
and photoreceptors are nourished by the choriocapillaris via short and long posterior ciliary 
arteries (Kaufman and Alm 2003). In adults, both the vascular beds (i.e. retina and choroid) 
vary in their embryonic differentiation pattern as well as in their function. Retinal vessels 
do not exhibit fenestrations similar to those observed in the brain, whereas the choroidal 
vessels are fenestrated (Saint-Geniez and D'Amore 2004). 
 
Despite varying metabolic demand, blood oxygen and carbon dioxide concentration, and 
perfusion pressure changes, the retina is capable of regulating blood flow. The magnitude 
of change in retinal hemodynamic measurements to provocative stimuli, such as that 
elicited by change in arterial blood partial pressure of carbon dioxide (PaCO2) or oxygen 
(PaO2) is known as “vascular reactivity”. Several studies have demonstrated changes in 
retinal vessel diameter, velocity and flow to various provocative stimuli such as CO2, O2 
and flicker (Luksch et al. 2002; Gilmore et al. 2005; Garhofer et al. 2011). Changes in 
retinal vascular reactivity and blood flow have been reported in major retinal diseases 
(Gilmore et al. 2007; Venkataraman et al. 2010). Ocular blood flow measurement 
techniques utilising Doppler technology are promising for early detection of hemodynamic 




1.1 Retinal blood supply and drainage 
Ocular blood supply is primarily derived from the ophthalmic artery (OA), a branch of the 
internal carotid artery. Three major branches of OA supply the extra ocular muscles, the 
central retinal artery (CRA), and the posterior and anterior ciliary arteries respectively 
(Hayreh 1962; Harris et al. 2003). The CRA enters the optic nerve from below, 
approximately 10-15mm behind the globe, from where it runs within the central portion of 
the optic nerve, adjacent to the central retinal vein (CRV). The CRA further subdivides 
into four major arteriolar branches supplying each quadrant of the retina. Venous blood is 
drained into the superior ophthalmic vein or directly into the cavernous sinus by the CRV, 
which leaves the eye through the optic nerve (Pournaras 2008).  
 
1.2 Choroidal blood supply and drainage 
The choroid is a mesh lying between the sclera and the retina. The choroid is rich in blood 
vessels and most of this blood is derived from posterior ciliary arteries. A medial and 
lateral posterior ciliary artery (PCA) branch runs from the ophthalmic artery. Before 
piercing the sclera, each PCA divides into a long posterior ciliary artery, which supplies 
the anterior choroid as well as into 10 to 20 short posterior ciliary arteries, which supply 
the posterior choroid. The deeper outer layers of the retina including photoreceptors and 
bipolar cells are specifically supplied by the choriocapillaris, a single layer of choroidal 
capillaries containing fenestrated endothelium without tight junctions (Jakobiec 1982). 
Venous blood from the choriocapillaris is drained through the vortex veins into the inferior 




further drains into the cavernous sinus (Hart and Adler 1992; Harris et al. 2003; Kaufman 
and Alm 2003). 
 
1.3 Structure of retinal blood vessels 
Retinal blood vessels include arterioles, venules and capillaries. The blood vessel wall 
consists of three layers namely: 1) innermost endothelial cells 2) middle layer of smooth 
muscle cells and 3) outermost adventitia (Kaufman and Alm 2003). The endothelial cells 
are monolayer of cells located between the circulating blood and the smooth muscle layer 
(Haefliger and Flammer 2001). It plays a significant role in the autoregulation of blood 
flow as described in the following section. The diameter of vascular lumen is controlled by 
the contraction and relaxation of smooth muscle cells (Rensen et al. 2007). The outermost 
adventitial layer protects and anchors the vessel to the surrounding tissue. 
 
Emerging from the nasal side of optic disc, the retinal vessels are arranged in a radial 
pattern temporally, and an arching pattern nasally. The retinal arteries and veins remain in 
the nerve fiber layer of the retina, whereas the arterioles and venules extend more deeply as 
they form major capillary networks: 1). Superficial radial peripapillary capillaries in the 
ganglion cell and nerve fiber layer and 2) an inner and outer layer of deep capillaries lying 
in the inner nuclear layer. Towards the periphery of the retina these capillary networks thin 





Retinal arterioles are small resistance vessels of 20-150μm in diameter, regulating the 
amount of blood delivered to the downstream capillaries. Capillaries are about 6-10μm in 
diameter, facilitating the exchange of nutrients, waste and other substances between the 
blood and interstitial fluid. The capillaries lack a smooth muscle layer, but are composed of 
the thin layer of endothelial cells, pericytes and basement membrane. The endothelial cells 
have tight junctions (zona occludens) which act as a blood retinal barrier preventing the 
movement of macromolecules from the lumen to interstitial space, similar to that of blood 
brain barrier. The capillaries drain the blood into venules. These venules gradually become 
thicker in diameter and form veins. The veins have thinner vessel wall compared to arteries 
but have a larger cross sectional area to enable the storage of blood (Kaufman and Alm 
2003). 
 
1.4 Autoregulation of retina 
Autoregulation is defined as the “ability of the vasculature to maintain blood flow at 
relatively constant levels despite moderate variations in perfusion pressure” (Guyton 
1964). Retina is effectively autoregulated over a substantial range of intraocular pressure 
and systemic blood pressure (Lester et al. 2007; Robinson and Riva 1986; Schulte 1996; 
Grunwald et al. 1982). The vascular endothelial cells lining the blood vessel wall releases 





1.4.1 Metabolic, Myogenic and Neurogenic autoregulation 
1.4.1.1 Metabolic autoregulation  
Metabolic autoregulation is the ability of the vasculature to modulate blood flow in order 
to maintain metabolic components including tissue oxygen and carbon dioxide at relatively 
constant levels (Guyton 1964). The term ‘metabolic autoregulation’ is often referred as 
‘vascular reactivity’. Increased tissue concentration of oxygen and decreased concentration 
of carbon dioxide results in vasoconstriction. Conversely, increased tissue concentration of 
carbon dioxide and decreased tissue oxygen concentration results in vasodilation. 
However, it is interesting to note that these responses occur, independent of perfusion 
pressure (Johnson 1986). 
 
1.4.1.2 Myogenic autoregulation  
Myogenic autoregulation is responsible for maintaining constant blood flow despite 
increase in arterial pressure by contracting the smooth muscle of the vessel wall, thereby 
reducing the blood flow. Conversely, at low pressures, the smooth muscle relaxes and 
allows increased blood flow. The stretching of smooth muscle increases calcium ion entry 
from the extra cellular fluid into the smooth muscle cell resulting in contraction (Guyton 
and Hall 2000). Endothelial derived vasoactive agents are thought to play a major role in 





1.4.1.3 Neurogenic autoregulation  
Since the sympathetic nerves supply the retinal vasculature only up to lamina cribrosa, the 
autonomic nervous system does not contribute to the autoregulation of retina (Harris et al. 
2003). 
 
1.5 Endothelial derived vasoactive substances 
The endothelial cells lining the retinal vessels synthesize certain substances which, when 
released, can affect the degree of relaxation and contraction of the arterial wall (Guyton 
and Hall 2000). They are: 
 1). Endothelial derived relaxing factor (EDRF) and 
2). Endothelial derived constricting factor (EDCF).  
These substances are primarily responsible for local retinal blood flow regulation. Previous 
studies reported that altered production of either of these substances result in patho 
physiological diseases including arterio-sclerosis, hypercholesterolemia, hypertension and 
diabetes (Hsueh and Anderson 1992; Davignon and Ganz 2004). 
 
1.5.1 Endothelial derived relaxing factors 
1.5.1.1 Nitric oxide 
Nitric oxide (NO) is a potent endothelium-derived relaxing factor, produced when L-
arginine is transformed to L-citrulline by catalysis of nitric oxide synthase (NOS) in the 
presence of oxygen and cofactors including calmodulin, tetrahydrobiopterin (BH4), 




dinucleotide, and flavin mononucleotide. NO binds to the iron atom of heme in guanylate 
cyclase and thereby increases intracellular cyclic guanosine monophosphate levels, in turn 
leading to a decrease in intracellular calcium levels and hence vasorelaxation (Gornik 
2004). 
 
Various studies indicate the role of NO in controlling blood flow by maintaining 
hypercapnia induced vasodilation (Schmetterer and Polak 2001), although the underlying 
mechanism is yet to be clearly understood. NO is also previously reported to regulate blood 
flow by initiating vasodilation of retinal vessels in response to flicker stimuli (Dorner et al. 
2003).  
 
1.5.1.2 Other endothelial derived vasodilators 
Prostacyclin (PGI2) is also a vasodilator synthesized by endothelial cells from arachidonic 
acid. It acts through the activation of adenylate cyclase, leading to increased levels of 
cyclic adenosine monophosphate. It is the most potent inhibitor of platelet aggregation 
(Vane and Botting 1995; Kaufman and Alm 2003). 
 
1.5.2 Endothelial derived constricting factors 
1.5.2.1 Endothelin 
The endothelins (ET) are a group of vasoconstricting agents released by endothelial cells. 
Endothelins consist of three 21-amino acid peptides: ET-1, ET-2 and ET-3 which act 




receptor is found on vascular smooth muscle cells, whereas ETB receptor is found on 
vascular endothelial cells. ETA receptors mediate vasoconstriction secondary to increased 
intracellular calcium (Schiffrin 1998; Lüscher 1997). Various animal (Granstam et al. 
1992) and human studies (Dallinger et al. 2000) have reported the role of ET-1 in initiating 
pronounced vasoconstricting response to hyperoxia in retinal vasculature. 
 
1.5.2.2 Other endothelial derived constricting factors 
Norepinephrine and epinephrine are other vasoconstrictive hormones released by 
endothelial cells. Both are neurotransmitters released by adrenal medulla, which activates 
the sympathetic nervous system, which excites the heart and contracts the vein and 
arterioles. Norepinephrine is known to be more potent than epinephrine; in some tissues 
epinephrine was even known to cause mild vasodilation (Goodall and Norman 1958). 
 
Angiotensin II and vasopressin are other vasoconstrictors to be mentioned. Though 
vasopressin is known to be more powerful than angiotensin II, the later substance 
powerfully constricts the small arterioles. If this occurs, the blood flow to that area of 
tissue could be significantly depressed (Goodall and Norman 1958; Guyton and Hall 
2000). 
 
1.6 Vascular reactivity 
The magnitude of change in retinal hemodynamic measurements to provocative stimuli, 




or oxygen (PaO2) is known as “vascular reactivity”. Hyperoxia is an increase in arterial 
partial pressure of oxygen from baseline homeostatic levels; endothelin-1 is known to 
mediate the vasoconstrictive response to hyperoxia (Dallinger et al. 2000). On the other 
hand, hypercapnia refers to an increase in arterial partial pressure of carbon dioxide from 
baseline homeostatic levels; nitric oxide is thought to regulate blood flow by maintaining 
vasodilation during hypercapnia (Goldstein et al. 1996; Schmetterer et al. 2001). 
 
Retinal vessels react to hyperoxia by local constriction of arterioles, venules and 
capillaries; thereby reducing the retinal blood flow (Gilmore et al. 2004; Sponsel et al. 
1992). Conversely, hypercapnia induces vasodilation of blood vessels which increase the 
blood flow (Venkataraman et al. 2006; Venkataraman et al. 2005; Venkataraman et al. 
2008; Dorner et al. 2002; Luksch et al. 2002). Previous studies have shown that cerebral 
vessels react to hypercapnia and hyperoxia similar to retinal vessels (Schmetterer et al. 
1997). However, inner retinal circulation was shown to be more sensitive to increased 
partial pressure of oxygen than carbon dioxide than the cerebral vessels. On the other hand, 
the cerebral vasculature was shown to react greater to carbon dioxide while showing no 
significant response to oxygen (Kisilevsky et al. 2008). 
 
1.7 Physiological principles of blood flow 
‘Blood flow’ refers to the “quantity of blood that passes a given point in the circulation in a 
given period of time” (Guyton and Hall 2006). Blood flow is normally measured in 




cells and blood vessel diameter refers to the horizontal distance across the lumen of the 
vessel wall. 
 
When blood flows with a steady rate along the vessel, the flow is ‘streamlined’, with each 
layer of blood remaining equidistant from the vessel wall. This manner of flow is known as 
‘laminar flow’. If blood flows in this fashion through the vessel wall, a parabolic pattern 
develops between the layers of the blood, i.e. the velocity of center layer is much faster 
compared to the adjacent layers towards the vessel wall. The layer touching the vessel wall 
has poor velocity due to its adherence to the vessel wall. In contrary to laminar flow, if the 
rate of flow is much greater, i.e. when blood passes through a bifurcation or any 
obstruction within the vessel wall, then the usual parabolic pattern is disturbed resulting in 





(a)                                                          (b) 
 
 Figure 1.1 Types of flow inside a blood vessel (a) Laminar flow; (b) Turbulent flow 
 
Blood flow (Q) inside a vessel wall is directly proportional to perfusion pressure (∆P), 
which is the difference in pressure between two ends of the vessel; and inversely 





between moving blood and endothelial cell layer. The relationship between flow rate, 
perfusion pressure and resistance based on Ohm’s law is given by: 
𝑄 =  ∆P
R
                                                                                           (1.1) 
Resistance to flow (R) is determined by the properties of fluid as well as the vessel in 
which the fluid is flowing. R is directly proportional to length of the vessel (L) and 
viscosity of the fluid (𝜂); whereas inversely proportional to fourth power of the radius (r) 
of the vessel. This relationship is given by: 
 R = 8ηL
πr4
                                                                                         (1.2) 
 
The Hagen-Poiseuille law gives the relationship between all the factors influencing blood 
flow through the vessel. 
    𝑄 =  ∆𝑃𝜋𝑟
4
8𝜂𝐿
                                                                                      (1.3) 
in which Q is the flow rate, ∆P is the pressure difference between two ends of the vessel, r 
is the radius of the vessel, 𝜂 is viscosity of the blood and L is length of the vessel. From the 
equation it is obvious that small change in the diameter of the vessel highly impact the 
flow to a tissue, since flow is directly proportional to the fourth power of radius of the 
vessel (Sparks and Rooke 1987). 
 
Perfusion pressure is the difference between arterial and venous pressure. Arterial pressure 




pressure in the eye is nearly equal to the intraocular pressure (Kaufman and Alm 2003). 
Therefore, ocular perfusion pressure (OPP) is expressed as the difference between arterial 
blood pressure minus intra ocular pressure (IOP) (Leske 2009). 
𝑂𝑃𝑃 = 2
3
𝐵𝑃𝑚𝑒𝑎𝑛 – 𝐼𝑂𝑃 ……………………………………………………….(1.4) 
Ocular perfusion pressure could be reduced by decreasing the mean arterial blood pressure 
or by increasing the IOP (Riva et al. 1997). 
 
1.8 Human retinal blood flow 
The retina receives 15% of ocular circulation as compared to 85% to choroidal circulation 
(Harris et al. 2003). The choroid has a high flow rate compared to the inner retina and brain 
(Linsenmeier et al. 2000), as well as sympathetic nerves control choroidal blood flow, 
whereas retinal blood flow is efficiently autoregulated to increase or decrease perfusion 
pressure by contraction and dilation of retinal resistance arterioles respectively (Vaz et al. 
2011). Previous studies have reported that retinal blood flow remains constant over a 
substantial range of intraocular pressure and systemic blood pressure (Robinson and Riva 
1986; Riva et al. 1986). With the flow being steady, blood flow rate (Q) can be expressed 
as a product of velocity and cross sectional area as below:  
    𝑄 = 𝑉𝑚𝑒𝑎𝑛 ∗ 𝑆…………………………………………………………………………… (1.5) 
where Vmean is the mean velocity of moving red blood cells, which is given by Vmax / 2; S is 





1.9 Retinal blood flow assessment techniques 
Ocular blood flow assessment may in the future play a vital role to diagnose and treat 
major ocular pathologies like ARMD, DR and Glaucoma. The assessment techniques that 
are discussed below are a brief overview of those which are used to assess ocular 
hemodynamics. Many of these techniques measure surrogate markers of retinal blood flow 
rather than assessing flow per se. For more detailed explanation of ocular blood flow 
measurement techniques please refer to Harris et al. 2003; Schmetterer and Garhofer 2007 
Harris et al. 2008.  
 
1.9.1 Fluorescein angiography  
Ocular blood flow can be assessed by passing ‘dye’ intravenously and photographing it as 
it passes through the retina and choroid. Fluorescein angiography was originally introduced 
by Novotny and Alvis (Novotny and Alvis 1961). During fluorescein angiography, a rapid 
sequence of serial photographs is taken after the administration of intravenous fluorescein 
to visualize and document choroidal and retinal blood flow (Hurley et al. 2009). This 
technique was later enhanced by employing video-angiography and scanning laser 
ophthalmoscopy. This modification to the angiographic technique resulted in improved 
image quality and spatial resolution. Though several attempts have been made to quantify 
retinal blood flow using angiographic technique, most approaches were based on the 
measurement of time required for the dye to pass through the retinal circulation. Invasive 
procedure and injection of dye are some of the limitations of this technique (Harris et al. 




1.9.2 Blue Field Entoptic technique 
This technique allows the viewer to visualize the movement of leukocytes (white blood 
cells) through their perimacular capillaries while gazing into bright blue illumination. Most 
probably the underlying phenomenon is that erythrocytes, but not leukocytes absorb short 
wavelength light; therefore the passage of leukocytes are perceived as flying corpuscles 
(Nakahashi et al. 1989). By comparing with their own entoptic observation, subjects can 
adjust the number of leucocytes, the mean flow velocity and the pulsatility of motion, from 
which the retinal blood flow and the flow pulsatility can be calculated. This method is 
limited due to subjective fatigue and poor reproducibility when repeated measurements are 
done in the same subject (Yap and Brown 1994). 
 
1.9.3 Retinal vessel analyser (RVA) 
The RVA system consists of a fundus camera, a high-resolution digital video camera and a 
personal computer with analyzing software. The diameter of arterioles and venules within 
one disc diameter from the optic disc were measured using this analyser (Garhofer et al. 
2012). A fundus image is captured and were digitalized and analysed in real time with a 
frequency of 50Hz to determine the diameter of retinal vessels. The time to measure a 
single value is 40ms, allowing upto 25 measurements per second (Blum et al. 1999). 
Though proven to yield reproducible vessel diameter measurements (Polak et al. 2000), the 





1.9.4 Laser Doppler techniques 
The laser Doppler techniques are widely used in haemodynamic research to measure the 
moving red blood cell velocity. The Doppler shift principle is utilised in these techniques. 
(Figure 1.2) The principle of “Doppler shift” relates the frequency of sound or light 
reflected from an object to its velocity. When a laser light of frequency, is reflected from a 
moving particle like red blood cells (RBCs) it has a shift in frequency (∆f) that is 
proportional to the velocity of the moving RBCs. At the same time, light scattered from 
stationary tissue like vessel wall is not shifted in frequency (f) and so acts as the reference 









Red blood cells 









1.9.4.1 Colour Doppler Imaging (CDI) 
The CDI is an ultrasound technique that combines B-scan grey-scale imaging of tissue 
structure, colour representation of blood flow based on Doppler shifted frequencies and 
pulsed Doppler measurement of blood flow velocities. CDI measures the frequency of 
reflected sound waves to determine the blood flow velocity within the long and short 
posterior ciliary arteries, ophthalmic artery and central retinal artery (Harris et al. 2003). A 
potential source of error in CDI is the excessive pressure applied to the eyelid. This 
pressure can result in a significant change in IOP and can lead to changes in perfusion 
pressure and blood flow (Harris et al. 1998). Also operator experience is critical to acquire 
repeatable hemodynamic values (Baxter and Williamson 1995), probably due to the fact 
that the derived velocities are dependent upon the probe angle relative to the moving red 
blood cells. CDI cannot measure diameter of retinal vessels so quantitating retinal blood 
flow is impossible.  
 
1.9.4.2 Laser Doppler Flowmeter (LDF) 
The LDF is a non-invasive technique that allows the measurement of relative blood 
velocity, volume and flow within a tissue sampled by the laser beam. LDF measures 
volumetric flow within the retinal and choroidal capillaries (Harris et al. 2008). The 
advantage of this technique is the measurement of volumetric flow as compared to other 
techniques like laser Doppler velocimetry, which are only restricted to blood velocity 
measurements. The major limitation of LDF is that, the measured Doppler shift frequencies 
might be from both retinal and choroidal vasculature, therefore interpreting LDF data is 




1.9.4.3 Bi-directional Laser Doppler Velocimetry (BLDV) 
The BLDV measures the velocity of red blood cells by detecting the frequency shifts in 
laser light using ‘two’ photo-detectors (Harris et al. 1998). The absolute quantification of 
centerline blood velocity is possible by determining the difference in frequency shifts in 
two directions as represented by wave vectors K1 and K2 (Figure 1.3). The two photo-
detectors with a known angle of separation record the centerline blood velocity 
independent of the angle between the moving erythrocytes and reflected beam (Riva et al. 
1985). Velocity is determined using the equation: 
𝑉max= 𝜆∆𝑓𝑛∆𝛼 𝑐𝑜𝑠𝛽
                                                                                                             (1.6) 
where,  
∆𝑓 =  𝑓2 𝑚𝑎𝑥 − 𝑓1 𝑚𝑎𝑥 = (𝛼2 − 𝛼1)𝑣/𝜆                                                                       (1.7) 
From the above equations, f1 max and f2 max are the maximum frequency shifts at K1 and 
K2, respectively. α1 and α2 are the angles between the velocity vector Vmax and K1 and K2. 
∆α is the angle between K1 and K2; β is the angle between the vector Vmax and the incident 
beam.  
BLDV is capable of measuring blood velocity from major retinal vessels. If vessel 
diameter measurements are obtained separately, then volumetric retinal blood flow can be 
derived from the following equation (Kida et al. 2002; Feke 2006): 
    Flow = 1/2.𝜋.D2/4.Vmean.60                                                                         (1.8) 














Figure 1.3 Diagram illustrating principle of bidirectional laser Doppler velocimetry 
 
1.9.4.4 Canon Laser Blood Flowmeter (CLBF-100) 
In contrast to all the above mentioned instruments which utilize laser Doppler technique, 
the CLBF achieves simultaneous measurement of blood velocity and vessel diameter, thus 
volumetric retinal blood flow is derived in absolute units. The CLBF is a fundus-camera 
type device with two photo-detectors and two lasers. Two sequential velocity 
measurements are achieved using bi-directional techniques from the maximum frequency 
shifts at each photomultiplier along two optical paths (path 1 and path 2), to ensure 
consistency and to obtain single velocity measurement. A red diode laser (675 nm, 80 µm 
x 50 µm oval) measures velocity every 0.02 seconds across a 2 second measurement 
window resulting in velocity-time trace. A green diode vessel tracking laser system 


















measurement site. The vessel tracking system holds the laser in position to compensate for 
any eye movement while taking measurements (Harris et al. 2008). Diameter 
measurements are acquired during the first and final 60 ms of the 2-s velocity measurement 
window every 4 ms. The CLBF automatically corrects for the magnification effects 
associated with refractive and axial component of ametropia, to provide absolute 
measurement of velocity (mm/sec), diameter (μm) and flow (µl/min). The repeatability and 
consistency of the CLBF has been reported by many researchers (Kida et al. 2002; Guan et 
al. 2003; Rose and Hudson 2007; Yoshida et al. 2003). The CLBF is limited to 
measurements on vessels less than 60µm in diameter. A study conducted using in vitro 
model reports that CLBF requires relatively clear ocular media, if not significant errors 
might occur in vessel diameter measurements (Azizi et al. 2007).  
 
1.9.4.5 Doppler Spectral- / Fourier- Domain Optical Coherence Tomography (SD-OCT 
/ FD-OCT) 
Doppler SD-OCT is a novel technique for non-invasive quantitative measurement of total 
retinal blood flow in absolute units. Doppler SD-OCT utilizes the principle of ‘Doppler 
effect’ to determine the velocity of moving red blood cells. This spectrometer based OCT 
system contains a superluminescent diode with a center wavelength of 841nm and a 
bandwidth of 49nm. The axial resolution is 5.6 µm in tissue and transverse resolution is 20 
µm as limited by optical diffraction of the eye. The composite signal produced by the 
interference between the sample and reference arm light in the fibre coupler is detected by 
a custom spectrometer, consisting of 1024-pixel line-scan camera. Fourier transformation 




neural layers of the retina, each of which has differing reflectance properties (Figure 1.4). 
The phase difference between sequential axial scans at each pixel is used to determine the 
Doppler shift (Wang et al. 2009; Wang et al. 2007; Wang et al. 2008). 
 
To derive total retinal blood flow measurement, Doppler scans are acquired using RTVue 
FD-OCT (Optovue Inc., Freemont, CA) using a double circular scan protocol (DCSP) 
(Wang et al. 2009). The DCSP consist of two concentric circles of diameter 3.4 and 
3.75mm respectively. These two circles transect all large retinal arterioles and venules 
located near the optic nerve head in two locations. A total of six dual circular scan frames 
were obtained and averaged for each ring. From the measured Doppler shift with in the 
vessel and Doppler angle estimation from the vessel center depth difference between two 
concentric rings, volumetric flow is automatically achieved using a semi-automated 
software algorithm named Doppler Optical Coherence of Retinal Circulation (DOCTORC) 
(Konduru et al. 2012). Total retinal blood flow is calculated by summing up flows from all 
branch veins at one point in time (Wang et al. 2009). 
 
Figure 1.4 Schematics of a spectrometer based Fourier-domain OCT system 




1.10 Extraneous factors influencing retinal blood flow 
A plethora of evidence suggest that factors such as smoking (McVeigh et al. 1996; 
Steigerwalt et al. 2000; Silvestrini et al. 1996; Rogers et al. 1984), hyperglycemia (Gilmore 
et al. 2007; Chittari et al. 2011), caffeine (Terai et al. 2012; Mathew and Wilson 1985; 
Lotfi and Grunwald 1991) and high fat diet (West 2001) are well known to alter the 
vascular reactivity and blood flow in various vascular beds in humans. The effect of 
cigarette smoking on retinal hemodynamics deserves more attention, since growing 
evidence from epidemiological studies indicate positive association between smoking and 
Age Related Macular Degeneration (ARMD) (Thornton et al. 2005; Cheng et al. 2000; 
Klein et al. 1993; Smith et al. 1996; Vingerling et al. 1996; Cong et al. 2008). ARMD is 
currently the leading cause of irreversible blindness in developed countries (Friedman et al. 
2011; O'Shea 1996). Recent studies emphasize the increased risk of ARMD by two to 
three- fold in current cigarette smokers compared to non-smokers (Thornton et al. 2005; 
Seddon et al. 2006). Free radicals from cigarette smoke increases oxidative stress on the 
retinal pigment epithelium (RPE) - photoreceptor interface where metabolic activity is at 
its highest (Bertram et al. 2009).  
 
Cardiovascular studies suggest that smoking has detrimental effects on endothelial-derived 
vasodilation and nitric oxide biosynthetic pathway in humans (Barua et al. 2001; Zeiher et 
al. 1995). Cerebrovascular research also reports that smoking impairs cerebrovascular 





Several studies have reported the effect of smoking on retinal vascular reactivity; however 
the results seem to be controversial. Robinson and co-workers (Robinson et al. 1985) 
reported a 12 % (+ 5%) increase in macular leukocyte velocity and presumably retinal 
blood flow in smokers. Langhans and co-workers (Langhans et al. 1997) reported that 
smokers showed a reduced reactivity to oxygen compared to non-smokers. Surprisingly, 
Wimpissinger and co-workers (Wimpissinger et al. 2005) reported that oxygen reactivity 
of retinal vessel diameter was significantly more pronounced in smokers than non-
smokers. Clearly, the retinal vascular reactivity and blood flow changes in cigarette 
smokers remains ambiguous. 
 
1.11 Summary 
In summary, the retinal vascular bed is unique due to the fact that non-invasive direct 
visualization of microcirculation is possible. Retinal blood flow is efficiently 
autoregulated. In the absence of direct sympathetic innervation, metabolic and myogenic 
stimuli play a major role in autoregulation of the retina. Several studies have reported 
vascular reactivity of retina to various provocative stimuli including flicker (Dorner et al. 
2003) and inspired gas challenges (Dorner et al. 2002; Gilmore et al. 2004; Luksch et al. 
2002). In healthy individuals, retinal vessels vasoconstrict to hyperoxia due to the release 
of Endothelin-1 from vascular endothelium, whereas they vasodilate to hypercapnia, due to 
the release of nitric oxide. However, in healthy young smokers, impaired endothelium 
dependent vasodilation has been reported in several vascular beds, including the brachial 
artery (Ozaki et al. 2010; Barua et al. 2001) and coronary artery (Zeiher et al. 1995). 




induced retinal vasodilation in young healthy smokers. A few other studies also report 
impaired retinal vascular reactivity to gas provocation stimuli in smokers (Morgado et al. 
1994; Wimpissinger et al. 2005; Langhans et al. 1997). 
 
Though various techniques exist to measure retinal blood flow non-invasively, almost all 
of them have certain limitations. Some of the techniques may not be suitable for routine 
clinical practise due to high variability in retinal blood flow measurements (Garhofer et al. 
2012). At present, only the CLBF and Doppler SD-OCT enables the quantification of 
retinal blood flow in absolute units. The CLBF is capable of simultaneously measuring 
blood velocity as well as blood vessel diameter. The reproducibility and repeatability 
remain well established (Yoshida et al. 2003; Kida et al. 2002; Guan et al. 2003; Rose and 
Hudson 2007). The recently introduced Doppler SD-OCT measures total retinal blood flow 
in absolute units for the first time using a “dual scan protocol” (Konduru et al. 2012; Wang 
et al. 2007; Wang et al. 2008). However, careful validation of new techniques is mandatory 











2 Rationale, Hypotheses and Aims  
2.1 Rationale 
Retinal hemodynamic research has grown significantly over past two decades considering 
the need to understand and diagnose retinal diseases, given the improvement in the ability 
to quantify ocular blood flow. Retinal blood flow changes might be a pre-cursor for major 
retinal disease including glaucoma (Grieshaber and Flammer 2005), diabetic retinopathy 
(Bursell et al. 1996) and age-related macular degeneration (Chung et al. 1999). Various 
measurement techniques exist to study retinal hemodynamics. Those that utilize laser 
Doppler technology offer the possibility of measuring the velocity of moving red blood 
cells, in order to obtain retinal blood flow measurement. Some of the instruments which 
utilize Doppler technology are laser Doppler velocimetry (LDV) (Garhofer et al. 2012), 
laser Doppler flowmetry (LDF) (Feke 2006; Kagemann et al. 1998; Michelson et al. 1996) 
and color Doppler ultrasound imaging (CDI) (Schmetterer and Garhofer 2007).  
 
CDI measures the pulsatile component of the blood, however, retinal vessel diameter 
cannot be measured and therefore retinal blood flow measurement is impossible 
(Schmetterer and Garhofer 2007). With LDV only blood velocity of moving erythrocytes 
can be measured from a single retinal vessel at a time. In order to obtain retinal blood flow, 
additional retinal vessel diameter measurements need to be made separately. In contrast to 
LDV, the CLBF is capable of obtaining retinal blood velocity as well as vessel diameter 
measurements simultaneously to achieve volumetric retinal blood flow in absolute units 
(µL/min, mm/sec) (Guan et al. 2003). However obtaining total retinal blood flow 




The introduction of laser Doppler spectral domain optical coherence tomography (Doppler 
SD-OCT) has the potential to greatly enhance the field of haemodynamic research. This 
high-resolution, cross-sectional retinal blood flow imaging technique offers the opportunity 
to study the retinal vascular bed more precisely (Wang et al. 2008). In vivo retinal blood 
flow measurements are achieved by using a double circular scan protocol (DSCP), around 
the optic disc which transects all branch retinal arterioles and venules simultaneously 
(Wang et al. 2011; Wang et al. 2008). Studies conducted in young healthy individuals 
report a coefficient of variability of 10.5% for total retinal blood flow (TRBF) 
measurements obtained using Doppler SD-OCT. This makes it the only measurement 
technique so far available, that has the potential to quantitate TRBF in absolute units. The 
blood flow measures achieved using Doppler SD-OCT was shown to be within the range 
of values attained using laser Doppler flowmetry (Wang et al. 2008). 
 
In order to obtain TRBF measurement using the Optovue SD-OCT, the Doppler signal 
information from the OCT data is analyzed using the Doppler OCT of Retinal Circulation 
(DOCTORC) grading software. Once the software completes the automatic processing of 
OCT data, a human grader then manually verifies the type of vessel (artery or vein) and 
refines the blood vessel position and, diameter in subsequent scans in order to achieve total 
retinal blood flow measurements. This method of calculating TRBF, might be subject to 
human error with respect to manual estimation of retinal vessel diameter as well as grading 
of the Doppler signal strength (i.e., assigning confidence score ranging from 0 to 5) in the 
cross sectional images of retinal vessels. Consequently, it is important to study the learning 




measurements. However, previous studies found that retinal blood flow measures derived 
from semi-automated Doppler OCT analysis obtained by two trained graders seemed to be 
similar and reproducible (Konduru et al 2012).  
 
Ongoing studies from our lab show that the TRBF values are repeatable in young healthy 
individuals. In chapter3, the potential influence of grader’s experience on TRBF 
measurements was determined to report the learning effect in using Doppler OCT semi-
automated grading software. In addition, we set out to determine the repeatability 
(variability of measurements obtained by same grader repeatedly grading the same dataset) 
and reproducibility (variability of measurements obtained by two different graders grading 
the same dataset) of the TRBF measurements among trained and novice graders. 
 
Systematic analysis of retinal hemodynamic change to inspired gas challenge has been 
reported by several research groups (Dorner et al. 2002; Luksch et al. 2002; Sponsel et al. 
1992; Roff et al. 1999). However, previous research from our lab (Gilmore et al. 2005; 
Gilmore et al. 2004), established a novel methodology to comprehensively assess retinal 
hemodynamic changes in healthy (Venkataraman et al. 2006; Venkataraman et al. 2005; 
Venkataraman et al. 2008) as well as in diseased cohorts to various hypercapnic and 
hyperoxic gas provocations (Venkataraman et al. 2010), (Gilmore et al. 2007).  
 
Little is known about the hemodynamic effects of cigarette smoking on retinal 
autoregulation. Studies on retinal vascular regulation in smokers remain controversial 




al. 1997) showed reduced retinal capillary reactivity to hyperoxia in smokers, whereas 
Wimpissinger and co-workers (Wimpissinger et al. 2004) reported that the retinal vascular 
reactivity in response to carbogen (5% CO2, 95% O2) remains unaltered in smokers. This 
necessitates the need to study whether smoking is paralled by a decreased, increased or 
unaffected retinal blood flow and vascular regulation using a standardized hypercapnic 
provocation. 
 
In chapter 4, retinal blood flow and vascular reactivity was investigated in young healthy 
smokers. Both acute and chronic effect of smoking was studied using Doppler SD-OCT 
methodology to comprehensively quantify total retinal blood flow, by achieving a more 
standardized and stable provocation of retinal vascular reactivity via constant changes in 















The study hypothesis for chapter 3 is that there will be a significant difference in total 
retinal blood flow measurements between trained and novice graders achieved using semi-
automated Doppler optical coherence tomography of retinal circulation (DOCTORC) 
software.  
 
The hypothesis for chapter 4 is that the retinal vascular reactivity to inhaled carbon dioxide 
will be reduced in otherwise healthy subjects who smoke when compared to non-smoking 
age-matched controls. The impact of both acute (after smoking) and chronic (before 
smoking) cigarette smoking on total retinal blood flow measurement has not been 















The aim of chapter 3 is to investigate  
1) The learning effect among novice graders  
2) The reproducibility of retinal blood flow measurements between two graders  
and  
3) The repeatability of retinal blood flow measurements derived using semi-automated 
DOCTORC analysis software.  
 
The specific aim of chapter 4 is to determine the effect of normoxic hypercapnia on retinal 
blood flow in individuals who smoke using Doppler SD-OCT, a new non-invasive 
technique to visualize and quantify total retinal blood flow. The study defines both the 














3 Grader learning effect and reproducibility of Doppler spectral domain optical 
coherence tomography derived retinal blood flow measurements 
3.1 Introduction 
Though retinal circulation is directly observable, quantitative non-invasive measurement of 
retinal blood flow was not possible until the evolution of laser Doppler techniques.  Laser 
Doppler techniques enable the non-invasive quantitative absolute measurement of the 
speed of moving red blood cells (RBCs) in a blood vessel (Feke et al. 1987). This 
technique is based on the principle of the ‘Doppler Effect’. The laser light incident on a 
stationary target (e.g. vessel wall) as well as moving particles (e.g. RBCs) gets scattered. 
The scattered light from the stationary target remains unaltered where as those scattered 
from moving particles is shifted in frequency.  
 
Laser Doppler velocimetry (LDV) measures the velocity of moving red blood cells. In 
order to determine volumetric flow rate in major retinal vessels, the diameter of retinal 
vessels is also necessary. Researchers have previously measured blood vessel diameter 
from a magnified retinal image (Riva and Feke 1981). By summing the blood flow 
measurements from individual retinal arteries or veins the total retinal arterial or venous 
blood flow rate was calculated. Though this method of estimating volumetric retinal blood 
flow is reliable and reproducible (Riva et al. 1985), it should be emphasised that blood 
vessel diameter measured from an enlarged retinal image might be prone to measurement 





Unlike the laser Doppler velocimetry, which is restricted to velocity measurements; the 
CLBF combines the laser Doppler technique (for velocity measures) with simultaneous 
vessel densitometry (for diameter measures), to quantitate centerline blood velocity (mm/s) 
as well as vessel diameter (µm) of retinal arterioles and venules. To ensure the consistency 
of velocity measurements obtained using CLBF, it uses a unique bi-directional technique, 
i.e. the difference in Doppler shift is recorded via two photo-detectors simultaneously. The 
calculated difference is used to determine the absolute velocity of moving red blood cells. 
The CLBF utilizes a vessel tracking mechanism to ensure the fixation stability during the 
measurements. Reliable and reproducible CLBF measurements were achieved by several 
research groups (Guan et al. 2003), (Garcia et al. 2002), (Yoshida et al. 2003). However, 
obtaining total retinal blood flow measurements using this technique seems to be restricted 
to retinal vessels with a cross-sectional diameter of less than 60 µm, and to specific 
arteriolar or venular site (Yoshida et al. 2003). 
 
Recently, Garhofer and co-workers (Garhofer et al. 2012) studied total retinal blood flow 
in a group of young healthy subjects using bi-directional laser Doppler velocimetry (for 
velocity measurements) and the dynamic retinal vessel analyser (DVA) (for diameter 
measurements). In their study, only retinal vessels of diameter greater than 60 µm were 
included for total retinal blood flow calculation. The authors have further mentioned that 
the LDV technique used in their study, was more time consuming, i.e. requires good 
fixation stability in order to obtain accurate velocity measurement from all major retinal 
vessels as well as retinal vessel diameter measurements obtained using DVA needs to be 




Considering the practical difficulties of these measurements techniques in achieving 
consistent TRBF data, there appears to be a growing need for instruments that are capable 
of attaining total retinal blood flow measurement with minimum acquisition time as well as 
optimum consistency. Previous research studies indicate the need for quantification of total 
retinal blood flow to better understand the pathophysiology of major retinal diseases 
(Cuypers et al. 2000; Logan et al. 2004). 
 
Doppler Spectral- / Fourier- Domain Optical Coherence Tomography (SD-OCT / FD-
OCT) overcome most of the limitations of existing laser Doppler methodologies in terms 
of retinal blood flow measurements. Doppler SD-OCT offers unparalled image resolution 
and acquisition time with a wide range of scan protocols and analysis options (Drexler and 
Fujimoto 2008; Geitzenauer et al. 2011). In addition to revealing precise morphological 
details of the retina, Doppler SD-OCT also has the potential to give retinal blood flow 
information in absolute units (µL/min) (Wang et al. 2011; Wang et al. 2008). 
 
Huang and co-workers (Wang et al. 2008) were the first to successfully demonstrate the in 
vivo volumetric retinal blood flow measurement in humans using Doppler SD-OCT. The 
total retinal blood flow values obtained using Doppler SD-OCT were reported to be 
reproducible in a group of healthy individuals and these values were also found to be 
within the range of laser Doppler flowmeter derived retinal blood flow values. However it 
should be noted that these values are lower than retinal blood flow values that were 





By combining the principles of laser Doppler velocimetry and optical coherence 
tomography, Doppler SD-OCT provides both structural and functional information of the 
retina. In Doppler SD-OCT, the absolute flow velocities of red blood cells and cross 
sectional area of the blood vessel are determined from the three dimensional structural 
OCT image of the retina, thus enabling quantification of total retinal blood flow (Wehbe et 
al. 2007). This way of achieving TRBF is made possible by using a semi-automated 
software algorithm named Doppler optical coherence tomography of retinal circulation 
(DOCTORC), in which retinal vessels are identified automatically by computer algorithms 
as arteries and veins based on their Doppler signal strength. However, a human grader 
needs to carefully verify the software defined vessel type with a corresponding fundus 
photograph of the retina. The cross-sectional areas, position of the vessels within the OCT 
scans need to be refined by a human grader. Konduru and co-workers (Konduru et al. 
2012) reported reproducible retinal blood flow measurements among trained graders, 
which were achieved using DOCTOC software. However, any potential impact of grader’s 
experience on TRBF measurements needs to be established.  
 
The hypothesis for this study is that there will be a significant difference in total retinal 
blood flow measurements between trained and novice graders achieved using semi-







3.2 Materials and Methods 
3.2.1 Sample 
Two experienced operators acquired Doppler SD-OCT scans from 15 eyes of 15 healthy 
subjects (mean age 28.13 yrs, SD + 4). One eye of each subject was randomly chosen for 
this study. Refraction, best corrected logMAR visual acuity, intra ocular pressure and 
resting blood pressure were assessed prior to the dilation of study eye with 1% tropicamide 
(Alcon, Mississauga, Canada). All subjects had a logMAR visual acuity of 0.0, or better. 
Subjects with refractive error > + 6.00 diopters sphere and / or + 1.50 diopters cylinder, 
history of any ocular disease, history of habitual smoking, cardiovascular disease, systemic 
hypertension and use of medications with known effects on blood flow such as anti-
hypertensive, medications with activity at autonomic receptors, smooth muscles, or those 
affects nitric oxide release are excluded from the study. All participants were asked to 
abstain from caffeine and red meat for 12 hours prior to the study visit. This study received 
approval by the University of Waterloo Office of Research Ethics. Informed consent was 
obtained from each subject after explanation of the nature and possible consequences of the 
study according to the tenets of the Declaration of Helsinki. 
 
3.2.2 Operators 
At the initial examination, SD-OCT image acquisition for all subjects was made by two 
trained operators. These two operators were trained in using the RTVue SD-OCT (Optovue 
Inc., Freemont, CA, USA) and were required to have acquired at least 15 SD-OCT images 




superior and 6 inferior pupil scans) were obtained using the circumpapillary double 
circular scan protocol of the RTVue SD-OCT. The reason to allow only trained operators 




One trained and one novice individual graded the 15 Doppler OCT images based on their 
Doppler signal strength and vessel area estimation using DOCTORC (Centre for 
Ophthalmic Optic and Lasers, CA, USA) software. The trained grader underwent formal 
training in using DOCTORC software at the Doheney Eye Institute, CA. The trained grader 
had successfully graded 20 practice cases and several additional subject datasets. The 
novice grader had no previous grading experience but was trained to understand the 
DOCTORC grading manual and the basic principles of grading from a trained grader.  
 
3.2.4 Sessions 
Each grader graded 15 Doppler OCT images in two sessions separated by a time interval of 
one week. The novice grader analysed five standard practice datasets established by the 
Doheney Eye Institute, CA in practise session 1 before beginning to grade 15 subject 
datasets for the study (session 1). After session 1, the novice grader received additional 
training grading 15 more practice datasets (practice session 2). Following the completion 
of practice session 2, the novice grader then re-graded the same 15 subject datasets (session 










     
Figure 3.1  Illustration of the grading sessions included in the study.  
 
3.2.5 Doppler SD-OCT 
The Doppler spectral-domain OCT is a novel imaging technique capable of providing the 
in vivo non-invasive assessment of retinal hemodynamics. The principle of ‘Doppler 
Effect’ has been incorporated into the commercially available Optovue RTVue SD-OCT 
(Optovue Inc, Freemont, CA). Laser light scattered from a stationary object such as a 
vessel wall remains unaltered in frequency while light reflected by moving red blood cells 
inside the vessel incurs a shift in frequency (fd). The relationship between Doppler 
frequency shit and velocity of red blood cells is given by 
 𝑓𝑑=2𝑛𝑣𝑎𝜆𝜊
 cosɵ                                                                                                                (3.1) 
where n is the refractive index of the medium, va is the absolute velocity of moving red 
blood cells, and λ0 is the central wavelength of the light source and ɵ is the Doppler angle 
(Wehbe et al. 2007). In order to calculate the absolute velocity from the measured Doppler 
Session 1 
 
Practice Session 1 
Novice Grader 
Session 1 
Practice Session 2 





shift of moving red blood cells, Doppler angle need to be known. In SD-OCT, Doppler 
angle is calculated from the acquired three dimensional data, which provides the structural 
orientation as well as Doppler signal information of retinal vessels within subsequent 
Doppler scans acquired around the optic disc using the RTVue SD-OCT. 
 
The scan protocol for retinal blood flow measurement consist of double circular Doppler 
scans in the form of two concentric rings of diameters 3.4 and 3.75mm centered on the 
optic nerve head, transecting all major branch retinal arteries and veins (Konduru et al. 
2012) (Figure 3.2). For image acquisition, the double circular OCT beam passes through 
the pupil nasally to acquire two sets (i.e. 6 scans in each set) of Doppler scans superiorly 
and inferiorly. The reason behind acquiring two sets of scan is to ensure good quality as 
well as to achieve optimum flow measurement from atleast one of the two sets of scans. In 
the real time display of the scan, the OCT beam position in the retina could be monitored 
from the sinusoidal variation in the vertical position of the retina (Figure 3.3).  
 
During each scan 30 to 36 frames of Doppler OCT image are registered for each ring. 
From the acquired SD-OCT images the Doppler angle is estimated by vessel centre depth 
difference within two consecutive circular OCT scans. The measured Doppler frequency 
shift along with the Doppler angle estimation, blood vessel diameter measurement from 
Doppler OCT image is used to compute absolute red blood cell velocity as well as retinal 






Figure 3.2 En face view of 3D OCT image showing double circular scanning protocol; the retinal vessels are 
labelled from 1 to 19. The red and blue color represents software identified vessel type as artery and vein 
respectively based on its Doppler signal. 
 
Figure 3.3 Doppler OCT image for OCT beam passing through the superior nasal quadrant of the pupil. The 
peak of the sinusoidal could be positioned within either superior or inferior quadrant of the pupil i.e. within 






3.2.6 Semi-automated Doppler OCT of Retinal Circulation (DOCTORC) software 
The acquired Doppler OCT scans along with the three dimensional optic disc SLO 
(scanning laser ophthalmoscopy) image are exported as raw data using RTVue Doppler 
transfer output software. The RTVue software converts the exported raw data into 
DOCTORC grading software (version 2.1.1.4) compatible data for image grading and 
retinal blood flow calculation (Konduru et al. 2012).  
 
Once the Doppler scan is loaded into DOCTORC, the software does initial automated 
assessment of the loaded scans, identifies the type of retinal vessel based on Doppler signal 
(i.e. artery or vein), and registers the Doppler scans with the 3D OCT image and SLO 
image. This way the grader could correlate the vessels that are identified on the en face 
image with those seen on the cross-sectional Doppler OCT B-scan image. A color fundus 
photograph of the optic disc is mandatory for grading to ensure whether the automatic 
vessel identification performed by the DOCTORC is appropriate. Upon successful 
completion of manual grading of Doppler OCT images, DOCTORC software then 
computes the blood flow results and automatically exports them into appropriate subject’s 
folder. 
 
3.2.7 Study Procedure 
The Doppler OCT images acquired by two experienced operators on 15 young healthy 
subjects were included for the study. The Doppler OCT scans were uploaded into the 
DOCTORC software for image grading and analysis. Both the trained and novice graders 




conducted in this study are explained in section 3.2.4. Both the graders manually selected 
every software identified vessel and graded them based on its Doppler signal strength, size 
and location between inner and outer rings, clarity of the vessel boundary, and then 
verified the type of vessel. From the cross-sectional B-scan Doppler image, the grader 
adjusted the blood vessel circumference using a dotted circle and diameter using a 
horizontal solid line (Figure 3.4). A confidence score ranging from 0 to 5 (Doheney Eye 
Institute, CA) was assigned by the grader to each vessel on every scan based on all the 
above mentioned parameters.  
 
Once the grading procedure is completed for all the visible retinal vessels in the Doppler 
OCT image, the software verifies whether or not the flow calculation for each graded 
vessel is valid, i.e. the veins included for the total retinal venous blood flow calculation 
should be atleast 50% or more of the total vein area; if not the blood flow result from that 
eye is considered unreliable. The grader must also carefully check if the flow (µL/min), 
velocity (mm/sec), and area (mm2) for all the graded vessels is anatomically acceptable; for 
example, smaller vessels must have a relatively smaller speed and lower flow compared to 
larger vessels. In the case where a particular vessel receives a poor confidence score, flow 
estimation could be made based on its vessel diameter measurement using the mean flow 
speed of all valid veins.  
 
Following the validity check by DOCTORC software, the total retinal venous blood flow 
was automatically computed by summing all calculated flow values from all valid veins 




comprising of retinal blood flow parameters achieved including total retinal venous blood 
flow (µL/min),  superior and inferior hemisphere venous blood flow (µL/min), superior 
and inferior venous area (mm2), venous velocity (mm/sec), arterial area (mm2) and arterial 
velocity (mm/sec) and were exported into the subject’s folder respectively. 
 
 
Figure 3.4 Cross-sectional image of blood vessel showing Doppler signal. Grader adjusts the vessel 









assigned by a grader to 




3.2.8 Statistical Analysis  
The mean total retinal blood flow (TRBF), venous area measurements of the trained grader 
was used as the standard to analyse any ‘learning effect’ for the novice grader. The mean 
values achieved by each grader during each session are plotted against the grading session. 
The mean and standard deviation for retinal blood flow parameters including TRBF, 
superior and inferior venous area, superior and inferior hemisphere blood flow, venous 
velocity, arterial area and arterial velocity measurements for the novice and trained graders 
for session 1 and session 2 were analyzed using one way analysis of variance (ANOVA).  
 
To quantify the reproducibility of repeated measurements obtained by the same grader, by 
different graders, and at different sessions, the repeatability and reproducibility were 
determined. The limits of agreement between graders and sessions were illustrated using 
Bland-Altman plots. Intra class correlation was also calculated (a value close to 1 indicates 
good reproducibility). For a trained grader, the co-efficient of variability (SD/mean in %) 
for TRBF and venous area measurement was assessed for sessions 1 and 2. 
 
The coefficient of repeatability was defined as 1.96 times the standard deviation of the 
differences between pairs of measurements in the same subject obtained during the same 
visit by the same observer divided by the average of the measurements of each pair of 
readings. The coefficient of reproducibility was defined as 1.96 times the standard 
deviation of the difference between measurements obtained from the repetition of the test 




measurements. As the differences follow a normal distribution, 95% of the differences will 
lie between -1.96 SD and +1.96 SD (Martin Bland and Altman 1986). Statistica software 
(StatSoft, Inc., Tulsa, OK, USA) version 11.0 and Medcalc software (trial version 11.5.0) 























Doppler scans analysed by both the trained and novice grader acquired from a total of 15 
eyes of 15 healthy subjects (mean age 28.13 yrs, SD + 4) were included for the data 
analysis. 
  
3.3.1 Learning effect 
Figure 3.5 & 3.6 shows mean TRBF and venous area measurements achieved by both the 
trained and novice grader in session 1 and session 2 respectively. In session 1, the TRBF 
achieved by a novice grader was 42.22 + 6.74 µL/min and by a trained grader was 46.04 + 
9.81 µL/min. Of all the other retinal parameters included for the data analysis, the learning 
trend was statistically significant for venous area measurements (ANOVA, p=0.03), but 
not significant for TRBF measurements (ANOVA, p=0.22). Both inferior (ANOVA, 
p=0.00) and superior (ANOVA, p=0.02) venous area measurements by the novice grader 
were statistically significant from those achieved by a trained grader (Table 3.1). Since a 
significant learning effect was observed, session 1 results were not considered for 

























Table 3.1 Comparison of mean, SD (standard deviation) of retinal blood flow parameters among graders for 
session 1. The p-values designate the significance of any change in retinal blood flow parameters between 








Mean + SD 
(Range) 
Novice Grader 





46.04 + 9.81 
(30.78 - 64.21) 
42.22 + 6.74 
(32.02 - 54.92) 
 
0.22 
Superior flow (µL/min) 
25.25 + 7.06 
(17.41 - 39.82) 
22.39 + 5.65 
(14.06 - 35.83) 
 
0.23 
Inferior flow (µL/min) 
20.79 + 6.66 
(10.11 - 34.57) 
19.83 + 4.65 
(12.59 - 26.53) 
 
0.65 
Venous area (mm2) 
66.58 + 12.88 
(48.30 - 93.74) 
56.98 + 10.13 
(43.75 - 75.81) 
 
0.03 
Superior venous Area 
(mm2) 
35.58 + 6.80 
(21.79 - 46.77) 
30.02 + 6.08 
(21.14 - 41.31) 
 
0.02 
Inferior venous Area 
(mm2) 
31.00 + 9.26 
(14.68 - 50.99) 
26.96 + 5.82 
(18.78 - 37.20) 
 
0.00 
Venous velocity (mm/s) 
11.68 + 2.33 
(7.53 - 16.97) 
12.61 + 2.70 
(9.35 - 18.96) 
 
0.32 
Arterial area ( mm2) 
42.64 + 6.80 
(32.29 - 58.24) 
40.7 + 8.44 
(27.92 - 61.96) 
 
0.30 
Arterial velocity (mm/s) 
17.94 + 4.55 
(11.04 - 26.07) 
17.88 + 4.51 









Figure 3.5 Mean total retinal blood flow (µL/min) achieved by novice and trained grader in session 1 and 




Figure 3.6 Mean venous area (mm2) achieved by novice and trained grader in session 1 and session 2 
respectively. Session 1 results show a significant difference in venous area measurements between trained 














































3.3.2 Inter grader reproducibility 
In session 2, both the trained and novice grader showed no statistically significant 
difference in TRBF (ANOVA, p=0.77 and ICC of 0.935) and venous area (ANOVA, 
p=0.07 and ICC of 0.953) measurement (Figure 3.7 & Figure 3.8). The venous velocity 
(ANOVA, p=0.17), arterial area (ANOVA, p=0.14) and arterial velocity (ANOVA, 
p=0.48) were also not significantly different among graders. The mean TRBF for session 2 
for the trained and novice grader was 45.29 + 9.28 µL/min and 44.39 + 7.36 µL/min 
respectively. The COR for retinal blood flow parameters achieved by two graders are 
shown in Table 3.2. The average confidence score (score of 0.5 to 1 indicates ideal grading 
score) achieved by both graders for each of 15 eyes graded during session1 and sessions2 
are shown in figures 3.9 & 3.10. Following the second practice session, the TRBF and 
venous area measurements achieved by a novice grader was in good agreement with a 
trained grader. Figures 3.11 & 3.12 show the Bland – Altman plots with limits of 














Figure 3.7 Box plots illustrating mean TRBF measurement (µL/min) achieved by trained and novice grader 
for session 2. 
 
 
Figure 3.8 Box plots illustrating mean venous area (mm2) measurement achieved by trained and novice 





 Table 3.2 Session 2 results showing the comparison of mean + SD (standard deviation) and range of retinal 
blood flow parameters achieved by trained and novice grader. Coefficient of reproducibility (COR) and ICC 
(Intraclass correlation) values between two graders is also presented. p<0.05 was considered as statistically 




Mean + SD 
(Range) 
Novice Grader 












45.29 + 9.28 
(30.64 - 66.06) 
 
44.39 + 7.36 














24.34  + 6.43 
(14.74 - 36.68) 
 
22.09 + 4.87 














20.94 +  5.40 
(13.07 - 30.65) 
 
22.30 + 5.52 














60.01 + 8.87 
(48.56 - 77.41) 
 
66.72 + 10.6 




             
0.953 








31.21 + 5.87 
(22.4 - 41.16) 
 
35.38 + 6.77 











Inferior venous  
area (mm2) 
 
28.89 + 5.82 
(18.36 - 39.21) 
 
31.34 + 6.46 














11.41 + 2.07 
(7.68 - 15.65) 
 
12.40 + 1.78 














43.88 + 4.39 
(38.09 - 53.16) 
 
41.22 + 5.32 














17.17 + 2.75 
(11.57 - 22.12) 
 
17.94 + 3.21 














Figure 3.9 Scatterplot illustrating average confidence score for each subject achieved by novice grader in 




Figure 3.10 Scatterplot illustrating average confidence score for each subject achieved by trained grader in 







Figure 3.11 Bland-Altman plot of agreement for total retinal blood flow (TRBF) shown as difference in 
TRBF measurements as a function of average TRBF between trained and novice grader. The solid line in 
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Figure 3.12 Bland-Altman plot of agreement for venous area measurements shown as difference in venous 
area measurements as a function of average venous area measurements between trained and novice grader. 











































Average of venous area (mm2) 
Trained and Trained_novice (Session 2) 
 




















3.3.3 Intra grader repeatability 
The retinal blood flow parameters achieved by the trained grader in two sessions were used 
to analyse the repeatability of TRBF measurements achieved using semi-automated 
DOCTORC software. Figure 3.11 shows a Bland and Altman plot for TRBF measurements 
achieved by a trained grader in two grading sessions. The overall COV for total retinal 
blood flow and venous area measurements for a trained grader was 20.90% and 17.64% 
respectively. The individual CORs (coefficient of repeatability) for TRBF, venous area 
measurements ranged from 0 – 21.43 µL/min (median 4.06 µL/min) and 0 – 18.75 mm2 
(median 3.69 mm2). The overall COR for TRBF and venous area measurements was 13.78 
µL/min (mean effect 45.67 µL/min) and 12.75 mm2 (mean effect 66.58 mm2) respectively 




























Figure 3.13 Bland-Altman plot of agreement for total retinal blood flow (TRBF) shown as difference in 
TRBF measurements as a function of average TRBF between sessions of a trained grader. The solid line in 
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The data from this study suggests that the grader must be thoroughly trained in using 
DOCTORC software, if not significant error might be introduced in terms of TRBF 
calculation. A novice individual can gain sufficient experience after 20 practice datasets 
were analysed, when using DOCTORC software. Konduru and co-workers (Konduru et al. 
2012) reported that the DOCTORC software could yield excellent reproducibility of TRBF 
measurements between trained graders. In the current study, we evaluated the grader 
learning effect as well as repeatability and reproducibility of the total retinal blood flow 
measurements derived using semi-automated DOCTORC software. 
 
In this study, the grader learning effect was thoroughly investigated. Session 1 results 
showed significant differences among trained and novice grader in superior and inferior 
venous area measurements. Though there was no significant difference observed in TRBF 
measurements, the difference in venous area estimation among graders might possibly 
influence TRBF values. Interestingly, upon completing the practice sessions, the venous 
area measurements achieved by a novice grader showed no significant difference from 
those achieved by a trained grader. However, one or two more sessions should have been 
conducted in order to look for the consistency of results achieved by a newly trained 
grader.  
 
The mean total retinal venous blood flow in the present study as measured in 15 healthy 
individuals was 45.29 µL/min with a SD of 9.28 µL/min, was comparable with the 




Wang and co-workers (Wang et al. 2008) reported the COV for TRBF measurement to be 
10.5% in a sample of ten subjects using Doppler SD-OCT. Recently, Garhofer and co-
workers (Garhofer et al. 2012) reported high interindividual variability in total retinal 
blood flow measurement (44.0 +13.3 µL/min) using laser Doppler velocimetry. In our 
study the overall variability of TRBF and venous area measurements between sessions 
within the same grader was 20.90% and 17.64% respectively.  
 
From a grader’s perspective, the reason for the high variability in TRBF and venous area 
measurements in this study might be due to the fact that the cross-sectional area of retinal 
vessels, confidence score assigned by a human grader based on the Doppler signal strength, 
and the positioning of the vessels within the subsequent Doppler scans might not be 
consistent between two grading sessions. Moreover, the cross sectional area for retinal 
vessels with poor Doppler signal was estimated based on the intensity shadow of that 
particular vessel on the B-scan Doppler OCT image. These factors might possibly 
influence the venous area measurement and the total retinal blood flow calculation. 
 
In the current study, in spite of the fact that the same Doppler OCT scans were graded 
repeatedly by the same grader (trained), the variability seems to be high for both the TRBF 
and venous area measurements. This needs to be kept in mind while analyzing Doppler 
OCT images to derive total retinal blood flow. However, the study limitations are that the 
learning effect in terms of TRBF measurements has not reached a complete plateau as 
shown in figure 3.6. Therefore at least two more sessions should have been conducted for 




only two operators were included in this study, though the operators were well trained, 
there could be a possibility of inter-operator variability, which was not analyzed; finally, 
the two graders involved in this study were not independent graders. The trained individual 
helped the novice grader during the practice sessions so as to improve the grading 
technique of the novice person. However, both graders performed the grading 
independently at two separate grading locations.  
 
Recent studies have reported that Doppler SD-OCT measures total retinal blood flow with 
high speed and optimum reproducibility (Wang et al. 2007; Wang et al. 2009; Wang et al. 
2008; Wang et al. 2011). Our data suggests that reproducible and repeatable retinal blood 
flow measurements could be achieved using DOCTORC software only when a grader is 
sufficiently trained and completes 20 practice cases before grading the subject data sets. 
We further emphasis that thorough practice and understanding of semi-automated 










4 Retinal Blood Flow and Vascular Reactivity in Chronic Smokers 
4.1 Introduction 
Cigarette smoking is considered to be one of the major risk factors for several ocular 
diseases. In particular, it is an independent, but avoidable risk factor for Age Related 
Macular Degeneration (ARMD). Cigarette smoke contains more than 4000 chemicals, 200 
poisonous gases and a number of unidentified chemical components (Rodgman and Perfetti 
2008). Nicotine and carbon monoxide are identified as two major constituents of cigarette 
smoke (Smith and Fischer 2001). The cytotoxic effects of free radicals found in cigarette 
smoke may be the main contributing factor in accelerating smoking-induced disease 
mechanisms (Burke and Fitzgerald 2003). 
 
Smoking enhances the generation of free radicals and decreases the level of antioxidants in 
the blood circulation. This places the eye at increased risk to damage due to elevated 
oxidative stress and the site of this damage is focused on the retinal pigment epithelium 
(RPE) - photoreceptor interface where metabolic activity is at its highest (Bertram et al. 
2009). A causal relationship between smoking and ARMD (Thornton et al. 2005; Cheng et 
al. 2000) has been clearly elucidated by many studies; especially the Beaver Dam Study 
(Klein et al. 1993), Rotterdam Study (Vingerling et al. 1996) and Blue Mountains Eye 
Study (Smith et al. 1996), all of which report a strong association between current smoking 
and exudative ARMD. Thus, the effect of cigarette smoking on retinal physiology is of 





Autoregulation in the purest meaning is defined as the ability of the vasculature to maintain 
blood flow at relatively constant levels despite moderate variations in perfusion pressure 
(Guyton and Hall 2000). On the other hand, metabolic autoregulation is the ability of the 
vasculature to modulate blood flow in order to maintain metabolic components including 
tissue oxygen and carbon dioxide at relatively constant levels. Metabolic autoregulation is 
otherwise known as “vascular reactivity” (Guyton 1964). The impact of smoking on retinal 
autoregulation, vascular reactivity and other ocular retinal hemodynamic parameters in 
otherwise healthy individuals is controversial. Retinal hemodynamic changes in smokers 
deserve more attention, since these changes might predispose an individual to sight-
threatening ARMD, essentially a disease with a clear vascular component in its patho-
physiology. 
 
Provocations with various mixtures of inhaled oxygen and carbon dioxide have been 
undertaken extensively by our research group in the past to assess retinal vascular 
reactivity in healthy (Gilmore et al. 2005; Gilmore et al. 2004; Venkataraman et al. 2006; 
Venkataraman et al. 2008) and diseased cohorts (Gilmore et al. 2007; Venkataraman et al. 
2010). It has been shown that both retinal and the cerebral vessels react similarly by 
constricting to oxygen (O2) and by dilating to carbon dioxide (CO2) (Dorner et al. 2002; 
Kisilevsky et al. 2008; Gilmore et al. 2004; Venkataraman et al. 2006).  
 
CO2 has been suggested to be more potent than O2 in provoking vascular reactivity in the 
retina (Sponsel et al. 1992), although Kisilevsky and co-workers (Kisilevsky et al. 2008) 




oxygen than carbon dioxide. The cerebral vessels react to carbon dioxide while showing no 
significant response to oxygen.  
 
Vascular reactivity to CO2 has long been used to test retinal and cerebrovascular 
hemodynamics. It has been shown that, increase in PaCO2 above normal resting values, 
termed “hypercapnia”, results in vasodilation of retinal vessels, thereby increasing retinal 
arteriolar blood flow. The loss of retinal vascular reactivity to CO2 provocation may 
provide in-sight into disease mechanisms and potential treatments (Venkataraman et al. 
2010; White and Markus 1997).  
 
In previous studies on smokers, retinal blood flow and autoregulation was assessed by 
breathing 100% oxygen (hyperoxia) in diabetic patients and controls using laser Doppler 
velocimetry before and after smoking. In both groups, smoking induced a marked decrease 
in retinal blood flow and the ability of retinal vessels to autoregulate immediately after 
smoking (acute effect), which was more pronounced in diabetics than in healthy controls 
(Morgado et al. 1994). Only a few studies investigated the chronic or long term effects of 
cigarette smoking in humans. Langhans and co-workers (Langhans et al. 1997) showed 
reduced reactivity in retinal and optic nerve head capillaries to hyperoxia in smokers, 
whereas Wimpissinger and co-workers (Wimpissinger et al. 2005) reported abnormal 
retinal vascular reactivity of the major retinal vessels to hyperoxia in smokers in terms of 
the diameter response although the change in retinal blood flow was comparable between 
the two groups. Smoking has been shown to markedly increase the basal cerebral blood 




(Wimpissinger et al. 2004) reported that the response to hypercapnia in chronic smokers is 
altered in the choroid, but not in the optic nerve or retina. Clearly, the vascular reactivity 
response of the retina to increase in PaCO2 in chronic smokers needs to be clarified.  
 
The hypothesis for this study is that the retinal vascular reactivity to inhaled carbon dioxide 
will be reduced in otherwise healthy subjects who smoke when compared to non-smoking 
age-matched controls. The impact of both acute (after smoking) and chronic (before 
smoking) cigarette smoking on total retinal blood flow measurement has not been 
simultaneously assessed on young healthy individuals who smoke.  
 
4.2 Materials and Methods 
4.2.1 Sample 
The sample comprises ten non-smokers (mean age 28.9 yrs, SD 4.58) and nine smokers 
(mean age 27.55 yrs, SD 4.77). The sample size calculation was determined after 
estimating the standardized effect size, i.e. Mean effect / SD, for retinal arteriolar blood 
flow. The two main studies that have investigated the effect of smoking on retinal vascular 
reactivity (Wimpissinger et al. 2004; Wimpissinger et al. 2005) have found diverse results, 
ranging from no difference between smokers and non-smokers to 100% difference. As an 
initial starting point, we will assume that smoking reduces the magnitude of vascular 
reactivity by 50%. Based on the results of Venkataraman and co-workers (Venkataraman et 
al. 2008), the effect of hypercapnia on mean retinal arteriolar blood flow in control subjects 




SD = (100-124.9) * 0.5 / 7 = 1.77. Assuming α=0.05 and a β of=0.90, sample size of n=7 
was estimated for each group. Conversely, if smoking reduces the magnitude of vascular 
reactivity by 25% then the required sample size will be 27. 
 
This study was approved by the University of Waterloo Office of Research Ethics, 
Waterloo, and by the University Health Network Research Ethics Board, Toronto. One eye 
of each subject was randomly chosen for this study. All subjects had a logMAR visual 
acuity of 0.0, or better. Smokers with a smoking history of at least 2 years and who 
regularly smoked 15-25 cigarettes per day were included. All the non-smoking participants 
had no previous history of smoking. Exclusion criteria included any refractive error > + 
6.00 Diopters sphere and / or + 1.50 Diopters cylinder, intra ocular pressure > 21mm Hg, 
treatable respiratory disorders (e.g. asthma), systemic hypertension, cardiovascular disease, 
diabetes, endocrine disorders, medications with known effects on blood flow (e.g.-anti-
hypertensive, medications with activity at autonomic receptors, smooth muscles, or those 
affects nitric oxide release.), family history of glaucoma, or a history of any ocular disease. 
All the participants were asked to abstain from caffeine, red meat and alcohol for 12 hours 
and avoid rigorous exercise about 1 hour prior to their study visit. Informed consent was 
obtained from each subject after a thorough explanation of the nature of the study and its 
possible consequences, according to the tenets of the Declaration of Helsinki. 
 
4.2.2 Study visit 
The study was performed during a single visit for all participants. However, non-smokers 




1.5 hour in length. The reason for having two session in the smoker group was to measure 
both the acute (after smoking) and chronic (after non-smoking period of about 6 hours) 
effect of cigarette smoking. 
  
4.2.3 Instrumentation 
4.2.3.1  Doppler Spectral Domain Optical Coherence Tomography (SD-OCT)  
The principle of the Doppler Effect has been incorporated into the commercially available 
Optovue RTVue OCT (Optovue Inc, Freemont, CA). Laser light scattered from a 
stationary object such as vessel wall remains unaltered in frequency while light reflected 
by moving red blood cells inside the vessel wall incurs a Doppler frequency shift (fd). fd is 
a function of the Doppler angle, ɵ, between the scanning beam and direction of flow as 




 cos ɵ                                                                                               (4.1) 
where n is the refractive index of the medium, Va is the absolute flow velocity, and λ0 is 
the central wavelength of the light (Wehbe et al. 2007).  
 
4.2.3.1.1 Instrument set up 
The Optovue Doppler SD-OCT system uses a super luminescent diode (SLD) with a center 
wavelength of 841nm and a bandwidth of 49nm. Its axial resolution is 5.6µm in tissue, 
while transverse resolution is 20µm as limited by optical diffraction of the eye.  Light 




(eye) and reference arm (reference mirror). The reflected light that comes back from these 
arms create an interference pattern which is captured by a CCD (charge-coupled device) 
line scanning camera located at the spectrometer output. Fourier transformation of the 
resulting interference pattern gives the sample depth profile or A-scan through the neural 
layers of the retina, each of which has differing reflectance properties. The phase 
difference between sequential axial scans at each pixel is used to determine the Doppler 
shift (Wang et al. 2009). 
 
4.2.3.1.2  Image acquisition and processing 
To acquire the retinal blood flow measurements, the SD-OCT beam is scanned on the 
retina around the optic nerve head (ONH) using a double circular scanning pattern of radii 
r1 = 3.4 mm and r2 = 3.45 mm in order to determine the angle between probe beam and 
blood flow (Konduru et al. 2012). Four pairs of Doppler SD-OCT images are sampled in 
each blood flow measurement during a total recording time of approximately 2 seconds 
(Wang et al. 2008). There are 3000 axial scans sampled in each circle. Each circle transects 
all branch retinal arterioles and venules.  
 
Total retinal blood flow is measured by summing up flow in the veins. The venules are 
identified by their centripetal flow direction. The reason for choosing branch veins for the 
flow calculation rather than arteries is that the latter have higher flow velocities that can 
cause excessive phase wrapping and Doppler signal fading (Wang et al. 2008). In Doppler 
SD-OCT, retinal blood flow is calculated in a semi-automatic fashion (Wang et al. 2007) 




Doppler signal for each vessel is graded manually for vessel diameter calculation using 
DOCTORC software (Doheney Eye Institute, CA) (Konduru et al. 2012). Following this, 
total retinal blood flow is automatically derived in absolute units (µL / min). Wang and co-
workers reported that the double circular scanning method using Doppler SD-OCT is a 
rapid and reproducible method to measure total retinal blood flow (Wang et al. 2009).  
 
4.2.3.1.3 DOCTORC software analysis for quantification of total retinal blood flow 
The acquired Doppler OCT scans along with the three dimensional optic disc SLO 
(scanning laser ophthalmoscopy) image are exported as raw data using RTVue Doppler 
transfer output software. This exported data is further converted to DOCTORC grading 
software (version 2.1.1.4) compatible data using the ReVue software (Optovue Inc.) and 
finally loaded into the DOCTORC software for image grading and retinal blood flow 
calculation. Once the Doppler scan is loaded into DOCTORC, the software does initial 
automated assessment of the loaded scans, identifies the type of retinal vessel based on 
Doppler signal (i.e. artery or vein), and registers the Doppler scans with the 3D OCT 
image, SLO image. From the cross-sectional B-scan Doppler image, the grader adjusts the 
blood vessel circumference using a dotted circle and diameter using a horizontal solid line. 
A confidence score ranging from 0 to 5 (Doheney Eye Institute, CA) is assigned by the 
grader to each vessel on every scan based on its Doppler signal strength, size and location 
between inner and outer rings, clarity of the vessel boundary. The total retinal venous 
blood flow is automatically computed by summing up calculated flow from all valid veins 





4.2.3.2 Canon Laser Blood Flowmeter (CLBF, model 100) 
The CLBF measures retinal blood flow (µL/min) in absolute units. The CLBF uses the 
Doppler shift to identify the fastest moving blood particles in the center of a retinal blood 
vessel and then calculates the average velocity. The CLBF is a fundus-camera type device 
with two photo-detectors and two lasers. Two sequential velocity measurements are 
achieved using bi-directional technique from the maximum frequency shifts at each 
photomultiplier along two optical paths (path 1 and path 2), to ensure consistency and to 
obtain single velocity measurement. A red diode laser (675 nm, 80 µm x 50 µm oval) 
measures velocity every 0.02 seconds across a 2 second measurement window resulting in 
velocity-time trace. A green diode vessel tracking laser system (543nm, 1500µm x 150µm 
rectangle) is used to stabilize the laser position at the measurement site. The vessel tracking 
system holds the laser in position to compensate for any eye movement while taking 
measurements (Harris et al. 2008). Diameter measurements are acquired during the first 
and final 60 ms of the 2-s velocity measurement window every 4 ms. The CLBF 
automatically corrects for the magnification effects associated with refractive and axial 
component of ametropia, to provide absolute measurement of velocity (mm/sec), diameter 
(μm) and flow (µl/min).  
Flow is calculated based on the assumption that the vessel wall has a circular profile and 
the flow is laminar with parabolic velocity profile (i.e. Poiseuille’s law) (Feke 2006). 
Hence flow through the vessel is calculated using the equation: 
F= Vmean x S                                                                                                                      (4.2) 
 where S is the cross-sectional area of the vessel at the site of measurement; Vmean is the 




V mean = V maximum / 2                                                                                                (4.3) 
(constant “2” assumes laminar flow obeying Poiseuille’s law). 
The repeatability and consistency of the CLBF has been reported by many researchers 
(Kida et al. 2002; Guan et al. 2003; Rose and Hudson 2007; Yoshida et al. 2003).  
 
4.2.3.3 Gas provocation 
The inspired and expired gas challenges were manipulated using a sequential rebreathing 
circuit. The sequential gas delivery breathing circuit (SGD; Hi Ox80, Viasys Healthcare, 
Yorba Linda CA) comprises a fresh gas reservoir and an expiratory gas reservoir. Each 
reservoir is connected to a face mask with separate one-way valves. The face mask covers 
the mouth and nose of the subject. In turn, the two reservoirs are inter-connected using a 
positive end-expiratory pressure (PEEP) valve which allows subjects to breathe exhaled 
gas (i.e. rebreathe CO2-enriched gas) when the fresh gas reservoir is depleted (Gilmore et 
al. 2004; Slessarev et al. 2006). The subject’s minute CO2 production and O2 consumption, 
gas flow and composition entering the SGD breathing circuit will be attained using an 
automated gas flow controller (RespiractTM, Thornhill Research, Inc., Toronto, Canada) 
which is connected to a computer. The distinguishing feature of the SGD and automated 
gas flow controller over other gas delivery systems  is the efficacy in ‘targeting’ end tidal 
gas concentrations, such that the software enables the user to repeatedly target PETCO2 and 








Figure 4.1 Schematic representation of the gas flow controller attached to a sequential gas delivery system 
(Image reproduced with permission from Elsevier (Exp Eye Res. 2008; 87(6):535-542). 
 
4.2.3.4 Breath carbon monoxide (CO) monitor 
CO Sleuth (Breathe E-Z Systems Inc., Leawood, KS) is a simple portable instrument 
which enables a non-invasive and direct measure of breath carbon monoxide level. The 
subject breathes out into a disposable mouth piece after holding the breath for 20 seconds. 
The end-tidal breath sample enters through a non-return valve, and reaches an 
electrochemical sensor. This novel sensor detects alveolar breath CO concentration, thus 
enabling the monitor to measure CO level in parts per million (ppm). CO concentration in 
alveolar breath was found to be highly correlated with blood carboxyhaemoglobin levels 





4.2.4 Fagerstrom Tolerance Questionnaire (FTQ) 
FTQ quantitates the nicotine dependency of a smoker. The daily and frequent pattern of 
compulsive smoking leads to the categorization of smoker as “dependent” (Fagerstrom and 
Schneider 1989). The questionnaire has a total of 7 questions regarding the smoking 
characteristics of an individual (Table 4.1). The FTQ has a scoring range of 0-11 points 
(Fagerstrom and Schneider 1989). A score of 0 indicates minimum nicotine dependence, 
whereas a score of 11 indicates maximum nicotine dependence. Under normal smoking 
condition, sampled CO was studied to be highly correlated with self-reported FTQ scores 
(Fagerstrom 1982; Tønnesen et al. 1988). The FTQ scoring scale to quantitate nicotine 
dependence was reported to be valid, reliable and applicable to adolescent smokers 
















S.No Questions Answers Score 
1. How many cigarettes a day do you smoke? 








3. Do you smoke more during the first 2 hours of the day than during the rest of the day? 
Yes 1 
No 0 
4. How soon after you wake up do you smoke your first cigarette? 
<30 min 1 
>30 min but before noon 0 
In the afternoon or evening 0 
5. Which cigarette would you hate to give up? 
First one in the morning 1 
Any other before noon 0 
Any other in the afternoon or in 
the evening 0 
6. Do you find it difficult to refrain from smoking in places where it is forbidden? 
Yes 1 
No 0 




Table 4.1 Fagerstrom Tolerance Questionnaire (obtained permission from Karl Fagerstrom to use the FTQ 











All subjects were made to complete a standard Fagerstrom Tolerance Questionnaire. Log 
MAR visual acuity (ETDRS log MAR charts) and intra ocular pressures (using the 
Goldmann Applanation Tonometer) were recorded for both eyes. One eye was randomly 
selected for the study and dilated with 1.0% Mydriacyl, Tropicamide (Alcon, Mississauga, 
Canada). Subjects were rested in sitting position for 10 minutes to stabilize baseline 
cardiovascular and respiratory parameters. Carbon monoxide level in the breath was 
analysed for all participants using CO Sleuth carbon monoxide monitor (Breathe E-Z 
Systems, Inc., Leawood, KS). Following that, participants were fitted with a face mask 
connected distally to the partial rebreathing circuit and the gas sequencer. An automated 
gas flow monitor connected to the rebreathing circuit was used to sample inspired and 
expired gases.  Retinal blood flow measurements were obtained using Doppler SD-OCT 
and CLBF, with duration of 45 minutes for each of these methodologies under three 
following conditions lasting for 15 minutes each: 
1). Baseline retinal blood flow (while breathing room air to establish baseline 
cardiovascular parameters). 2). Retinal blood flow during normoxic hypercapnia 
(approximately a 15% increase in end-tidal CO2 relative to the baseline). 3). Retinal blood 
flow during post-normoxic hypercapnia (while breathing room air to establish recovery 
from hypercapnia).  
 
Blood pressure, pulse rate and oxygen saturation were monitored continuously during the 
breathing period using a rapid response critical care gas analyzer (Cardiocap 5, Datex-




superior arteriole, away from bifurcations were acquired during each stage. For total retinal 
measurement using Doppler SD-OCT, a total of six scans (3 inferior nasal and 3 superior 
nasal) using ‘Double circular scan protocol’ were acquired during each breathing 
condition. The instrument order was randomized between subjects. 
 
For smokers, following completion of session 1 (approx. 1.5 hrs.), a break of 15 minutes 
was allocated, during which the examiner asked the subject to smoke one full cigarette. 
After the break, the subject was seated for 10 minutes during which the breath CO level 
was analysed and subject was fitted again with a face mask and seated comfortably to 
begin retinal blood flow measurements for session 2. It took almost 30 minutes to start 
obtaining retinal blood flow measurements after smoking. The order of instruments 
remained the same as with the previous session. Following completion of the study 
sessions, a colour fundus photograph of optic disc (Canon non-mydriatic fundus camera, 










4.2.6 Statistical analysis 
A repeated measures analysis of variance (reANOVA) was undertaken to determine any 
significant change in retinal blood flow and vascular reactivity between smokers and non-
smokers in CLBF and Doppler SD-OCT measurements. The dependent variables for CLBF 
measurements were retinal arteriolar diameter, blood velocity and flow, while the 
dependent variables for Doppler SD-OCT measurements were total retinal venous blood 
flow, venous area and venous velocity. In addition separate reANOVA was performed 
within each group (i.e., smokers and non-smokers) to determine the significance of any 
change of each dependent variable during baseline, normoxic hypercapnia and recovery. If 
a significant result was achieved using reANOVA, then post hoc testing was performed 
using Tukey’s HSD (Honestly Significant Difference) test. Significance of change of any 
systemic and gas parameters including PETCO2, PETO2, respiration rate, systolic and 
diastolic blood pressure, pulse rate and oxygen saturation were also analyzed using 
reANOVA.  
 
To determine the significance in total retinal blood flow measurements before and after 
smoking, in a small sample of smokers (n=7), a wilcoxon matched pairs test was 
performed. Due to small sample size, outliers were also included in the analysis. Carbon 
monoxide level in non-smokers and smokers (before and after smoking) was compared 
using one way-ANOVA. Statistica software (StatSoft, Inc., Tulsa, OK, USA) version 11.0 







4.3.1 Retinal vascular reactivity and blood flow in non-smokers 
A repeated measures ANOVA showed significant increase in retinal arteriolar diameter, 
blood velocity and flow by +4.1% (SD 2.8, p<0.0001), +16.7% (SD 14.6, p=0.0004) and 
+29.6% (SD 12.5, p<0.0001) during normoxic hypercapnia (Figure 4.2). Tukey’s HSD test 
revealed significant difference in diameter during hypercapnia relative to baseline 
(p=0.0014) and recovery (p=0.0002). Similarly, hypercapnia resulted in a significant 
difference in velocity measurements relative to baseline (p=0.0027) and recovery 
(p=0.0006). Retinal arteriolar flow during hypercapnic provocation was significantly 
different relative to baseline (p=0.0001) and recovery (p=0.0001).  
 
Venous area, venous velocity and total retinal blood flow significantly increased during 
normoxic hypercapnia by 7% (SD 8.6, p=0.0418), 18.1% (SD 20.8, p=0.0068) and 26% 
(SD 22.9, p<0.0001) respectively, analysed using reANOVA (Figure 4.3). A Tukey’s HSD 
test revealed significant difference in total retinal blood flow during hypercapnia relative to 
baseline (p=0.0001) and recovery (p=0.0001). Similarly, hypercapnia resulted in a 
significant difference in venous velocity measurement relative to baseline (p=0.0102) and 
recovery (p=0.0204). Though reANOVA showed a statistically significant difference in 
venous area measurement during hypercapnia (p=0.0418), post hoc testing (Tukey’s HSD 
test) does not show a significant difference in pairwise comparison between baseline and 







Figure 4.2 Box plots represent A) retinal arteriolar diameter; B) blood velocity; and C) blood flow at 














































Figure 4.3 Box plots represent A) venous area; B) blood velocity; and C) total retinal blood flow at baseline, 







































4.3.2 Retinal vascular reactivity and blood flow in smokers  
Retinal arteriolar diameter, blood velocity and flow changes during normoxic hypercapnia, 
were analysed using reANOVA. There was a significant increase in velocity by 12.0% (SD 
6.2, p=0.0019) and flow by 14.6% (SD 9.5, p=0.0029), and a non-significant increase in 
diameter by 1.7% (SD 1.7, p=0.2616) (Figure 4.4). A Tukey’s HSD test for pairwise 
comparison revealed significant difference in blood velocity compared to baseline 
(p=0.0194) and recovery (p=0.0019). Similarly, there was a significant difference in retinal 
arteriolar blood flow during normoxic hypercapnia compared to baseline (p=0.0076) and 
recovery (p=0.0058). 
 
A repeated measures ANOVA showed significant increase in total retinal blood flow 
(TRBF) by 19.3% (SD 18.4, p=0.002) during normoxic hypercapnia relative to baseline, a 
Tukey’s HSD test showed significant difference in TRBF measurement during hypercapnia 
compared to baseline (p=0.0035) as well as recovery (p=0.0087). However, there was no 
significant difference in venous area (p=0.3322) and venous velocity measurements 













Figure 4.4 Box plots represent A) retinal arteriolar diameter; B) blood velocity; and C) blood flow at 

















































Figure 4.5 Box plots represent A) venous area; B) blood velocity; and C) total retinal blood flow at baseline, 










































4.3.3 Comparison of retinal vascular reactivity and blood flow between smokers and 
non-smokers  
A one-way ANOVA showed significant difference in terms of percentage change in retinal 
arteriolar diameter response to normoxic hypercapnia between smokers and non-smokers 
(p=0.0379). Similarly, percentage change in flow was also significantly different between 
smokers and non-smokers (p=0.0101). However, blood velocity was not significantly 
different among the groups (p=0.3851) (Table 4.2), (Figure 4.6). There was no statistically 
significant difference in TRBF (p=0.3624), venous area (p=0.5669) and venous velocity 



















































Table 4.2 Group mean (SD) increase in retinal arteriolar diameter, blood velocity and flow in percentage 
change due to normoxic hypercapnia in non-smokers and smokers. Note: NS denotes not significant; Level of 







































Table 4.3 Group mean (SD) increase in total retinal blood flow (TRBF), venous area, and venous velocity in 
percentage change due to normoxic hypercapnia in non-smokers and smokers.  Note: NS denotes not 

















Figure 4.6 Percentage change from baseline in group mean A) arteriolar diameter; B) blood velocity and C) 




















































4.3.4 Comparison of retinal vascular reactivity and blood flow before and after 
smoking 
A Wilcoxon matched pairs test was performed to analyse the vascular reactivity to 
normoxic hypercapnia in terms of percentage change in diameter, velocity and flow before 
and after smoking. The percentage change in retinal arteriolar diameter, velocity and flow 
in response to normoxic hypercapnia after smoking was not significantly different when 
compared to before smoking. In addition, the percentage change in vascular reactivity in 
response to normoxic hypercapnia was also not significant in terms of total retinal blood 
















Figure 4.7 Box plots represent total retinal blood flow at baseline, normoxic hypercapnia and recovery as 
compared to before and after smoking. The center of the box represents group mean, the limits of the box 











4.3.5 Systemic and gas parameters 
In non-smoking group, PETCO2 was increased by 16% (SD 1.7, p<0.001) relative to 
homeostatic baseline with a concomitant non-significant increase in mean PETO2 by 0.9% 
(SD 2.1, p=0.29) in session 1a. There was a significant increase in mean PETCO2 by 15.9% 
(SD 2.9, p<0.001) relative to baseline with a concomitant significant increase in mean 
PETO2 by 1.8% (SD 0.5, p=0.005) in session 1b. There was no significant change in 
systemic parameters measured during different breathing conditions across both the study 
sessions (Table 4.4 & 4.5). 
 
In smokers, there was a 15.7% (SD 2.2, p<0.0001) increase in PETCO2 with a concomitant 
non-significant increase in PETO2 by 1.7% (SD 1.4, p=0.3135) in session 1a. There was a 
significant increase in PETCO2 by 15.7% (SD 2.6, p<0.0001) with a concomitant non-
significant increase in PETO2 by 1.4% (SD 4.2, p=0.2168) relative to baseline in session 1b. 
There was no significant change in any of the systemic parameters measured across both 
study sessions (Table 4.6 and 4.7). 
 
Baseline homeostatic PETCO2 values for non-smokers during session 1a and session 1b was 
33.67 + 3.15 mmHg and 33.48 + 3.66 mmHg respectively. For smokers, baseline 
homeostatic PETCO2 values during session 1a and 1b were 35.27 + 5.16 mmHg and 35.26 
+ 5.26 mmHg respectively. Repeated measures ANOVA showed no significant difference 
in PETCO2 (p=0.891) among groups. Similarly no significant difference was found among 




(reANOVA, p=0.3675) blood pressure, pulse rate (reANOVA, p=0.8148), respiration rate 
(reANOVA, p=0.145) and oxygen saturation (reANOVA, p=0.4309).   
 
In smokers, the homeostatic baseline value of PETCO2 after smoking was 36.89 + 5.43 
mmHg and 35.47 + 5.31 mmHg in session 2a and 2b respectively. This value is not 
significantly different form PETCO2 level before smoking. In session 2a pulse rate was 
significantly different in baseline (p=0.0279), during hypercapnia (p=0.0179) and recovery 
(p=0.0464) compared to before smoking, analysed using wilcoxon matched pairs test. 
Similarly, baseline respiration rate was significantly different (p=0.0267), as compared to 
before smoking, but showing no significant difference during hypercapnia and recovery. 
There were no other significant changes in PETO2, blood pressure (systolic and diastolic) 
and oxygen saturation. In session 2b, baseline diastolic blood pressure (p=0.0277) was 
significantly different before and after smoking. However, no significant changes observed 
in respiration rate during hypercapnia and recovery, before and after smoking. There were 
no significant changes in PETCO2, PETO2, systolic and diastolic blood pressure, pulse rate, 
respiration rate and oxygen saturation values during baseline, normoxic hypercapnia and 














Baseline Hypercapnia Recovery Re ANOVA 
PETCO2 
(mmHg) 33.6 + 3.1 39.0 + 3.7 33.3 + 3.4 p<0.0001 
PETO2 








71.5 + 8.9 71.6 + 10.5 73.0 + 9.8 NS 
Systolic blood pressure 
(mm Hg) 111.2 + 10 114.4 + 8.2 111.3 + 10.7 NS 
Diastolic blood pressure 





97.3 + 1.5 97.7 + 1.3 97.8 + 1.1 NS 
 
Table 4.4 Group mean (+ SD) for gas and systemic parameters across different breathing conditions (i.e., 
baseline, normoxic hypercapnia and recovery) in non-smokers during session1a. (PETCO2- partial pressure of 
end-tidal carbon dioxide, PETO2-partial pressure of end-tidal oxygen, O2 saturation – oxygen saturation) Note: 

















33.4 + 3.6 
 
38.7 + 3.7 
 







120.4 + 7.1 
 
121.8 + 7.2 
 




(breaths/min) 17.6 + 3.2 18.2 + 2.9 16.6 + 1.5 NS 
 
Pulse rate 
(beats/min) 71.6 + 8.8 72.2  + 8.8 70.3 + 9.3 NS 
Systolic blood 
pressure 
(mm Hg) 111.7 + 8.2 113.4 + 6.8 113.3 + 6.6 NS 
Diastolic blood 
pressure 
(mm Hg) 76.5 + 5.0 77.4 + 4.4 76.6 + 4.1 NS 
O2 saturation  
(%) 97.8 + 1.0 97.6 + 1.2 97.6 + 1.3 NS 
 
Table 4.5 Group mean (+ SD) for gas and systemic parameters across different breathing conditions (i.e., 
baseline, normoxic hypercapnia and recovery) in non-smokers during session1b. (PETCO2- partial pressure of 
end-tidal carbon dioxide, PETO2-partial pressure of end-tidal oxygen, O2 saturation – oxygen saturation) Note: 


















35.2 + 5.1 
 
40.7 + 5.7 
 







113.1 + 10.7 
 
114.7 + 10.1 
 







16.3 + 2.2 
 
16.2 + 2.5 
 







65.2 + 9.4 
 
66.4 + 7.9 
 
67.0 + 6.3 
 
NS 
Systolic blood pressure 
(mm Hg) 
 
109.0 + 15.6 
 
110.3 + 14.3 
 
109.3 + 14.8 
 
NS 
Diastolic blood pressure 
(mm Hg) 
 
66.8 + 11.0 
 
70.6 + 11.5 
 






97.3 + 1.4 
 
98.1 + 0.8 
 




Table 4.6 Group mean (+ SD) for gas and systemic parameters across different breathing conditions (i.e., 
baseline, normoxic hypercapnia and recovery) in smokers during session1a. (PETCO2- partial pressure of end-
tidal carbon dioxide, PETO2-partial pressure of end-tidal oxygen, O2 saturation – oxygen saturation) Note: NS 

















35.0 + 5.2 
 
40.5 + 5.6 
 






112.9 + 12.9 
 
114.1 + 11.4 
 






16.4 + 2.5 
 
17.0 + 2.9 
 






66.4 + 8.3 
 
67.1 + 7.6 
 







108.2 + 15.6 
 
111.6 + 14.0 
 
110.1 + 15.4 
 
NS 
Diastolic blood pressure 
(mm Hg) 
 
68.3 + 11.2 
 
71.3 + 10.7 
 






97.5 + 1.4 
 
98.0 + 0.9 
 




Table 4.7 Group mean (+ SD) for gas and systemic parameters across different breathing conditions (i.e., 
baseline, normoxic hypercapnia and recovery) in smokers during session1b. (PETCO2- partial pressure of end-
tidal carbon dioxide, PETO2-partial pressure of end-tidal oxygen, O2 saturation – oxygen saturation) Note: NS 










4.3.6 Breath CO  
Breath carbon monoxide (CO)  level  for non-smokers was 0.3 ppm (SD 0.4), smokers CO 
level before smoking was 3.33 ppm (SD 2.3), this difference was not statistically 
significant (p=0.1961) using one-way ANOVA. After smoking the CO level of smokers, 
was 8.42 ppm (SD 6.6), which was significantly different from CO level before smoking 
(p=0.0305) as well as from CO level of non-smokers (p=0.0006) (Figure 4.8). The 
Fagerstrom Tolerance Questionnaire (FTQ) score for non-smokers and smokers were 0+0 
and 3.33+2.2 respectively.  
 
 
Figure 4.8 Breath carbon monoxide level expressed in parts per million (ppm) in non-smokers and smokers 







 Retinal vascular reactivity has been widely studied using various gas provocation 
challenges including hyperoxia, hypercapnia and carbogen (gas mixture of 95% O2 and 5% 
CO2). An increase in arterial carbon dioxide concentration was shown to vasodilate retinal 
vessels (Venkataraman et al. 2008; Venkataraman et al. 2005). Similarly, an increase in 
arterial oxygen concentration constricts the retinal vessels (Gilmore et al. 2004; Gilmore et 
al. 2005; Werkmeister et al. 2012). In the present study, a sustained, stable and 
standardised hypercapnic stimulus was used for gas provocation in young healthy 
individuals. Studies from our own lab previously showed that, a 15% increase in PETCO2 
from standardised baseline while simultaneously maintaining isoxia increased the retinal 
arteriolar vessel diameter, blood velocity and flow by 3.3%, 16.9% and 24.9% 
respectively.  
 
Various other studies have assessed the retinal vascular reactivity to hypercapnic gas 
provocation. Dorner and co-workers (Dorner et al. 2002) reported that, to a 21% increase 
in PETCO2, retinal arteriolar and venular diameter increased by 4.2% and 3.2% 
respectively. Sponsel and co-workers (Sponsel et al. 1992) found a 26% increase in 
perimacular leukocyte velocity using blue field entoptic technique following inhalation of 
5% CO2. For a 10% increase in CO2 retinal arteriolar and venular diameter increased by 
+2% and 1% respectively as measured using fundus photograph (Frayser and Hickam 
1964). Venkataraman and co-workers (Venkataraman et al. 2006) reported 3%, 26% and 
35% increase in retinal arteriolar diameter, blood velocity and flow respectively in 




3.3%, 16.9% and 24.9% increase in retinal arteriolar diameter, blood velocity and flow 
respectively in response to 15% increase in PETCO2 using CLBF (Venkataraman et al.  
2008). In the present study retinal arteriolar diameter, blood velocity and flow increased in 
response to normoxic hypercapnia by 4.1%, 16.7% and 29.6% respectively using CLBF.  
 
Previous studies from various labs have achieved PETCO2 by manually adding CO2 to 
inspired air (Roff et al. 1999) or by rebreathing subject’s own exhaled gases (Harino et al. 
1995). Some studies have even failed to consider any concomitant change in PaO2 during 
hypercapnia (Roff et al. 1999). This way of achieving vascular reactivity response might be 
due to the combined effect of both PaO2 as well as PaCO2. In contrast, the technique of 
hypercapnic gas provocation used in our lab is unique in the sense that, arterial carbon 
dioxide concentration is increased whilst maintaining PETO2 at physiological resting level 
(Slessarev et al. 2007). So far, studies done by our Research Group confirm that the 
magnitude of normoxic (i.e. “clamping” of PaO2) hypercapnia induced using the computer-
controlled gas blender is highly repeatable (Venkataraman et al. 2010; Venkataraman et al. 
2008; Venkataraman et al. 2006; Venkataraman et al. 2005). 
 
In this study, we used the spectral-domain OCT Doppler technology to measure the total 
retinal blood flow, venous area and venous velocity changes in response to normoxic 
hypercapnia along with CLBF measurements. In interpreting the results from these two 
techniques, one needs to consider that they differ in terms of instrumental set up as well as 
site of measurement of blood flow. The Doppler OCT scans all branch retinal arterioles 




nerve head, whereas CLBF measures the blood velocity and diameter at a single location, 
in this case along the superior temporal arteriole, after the first bifurcation. 
 
For the first time, this study analysed the retinal vascular reactivity to normoxic       
hypercapnia using Doppler SD-OCT. Normoxic hypercapnia increased the venous area, 
venous velocity and total retinal blood flow by 7%, 18.1% and 26% respectively. 
However, the results of this study could not be directly compared to the previous studies, 
due to the technological differences in blood flow measurement and differences in 
magnitude of hypercapnic provocation. 
 
Few studies have assessed the retinal vascular reactivity to a hypercapnic stimulus in 
smokers. Wimpissinger and co-workers (Wimpissinger et al. 2004) reported that response 
to carbogen (5%CO2 and 95%O2) in chronic smokers is altered in choroid but not in the 
optic nerve head and retina. However, their results were restricted to only vessel diameter 
information; retinal blood flow was not assessed. In contrast to their results, results from 
the present study confirm that retinal arteriolar vascular reactivity (diameter and flow) is 
significantly reduced in smokers compared to non-smokers in response to normoxic 
hypercapnia. Though venous area and TRBF measurements showed a reducing trend in 
terms of magnitude of vascular reactivity, the results were not statistically significant; this 




Garhofer and co-workers (Garhofer et al. 2011) reported reduced flicker-induced 
vasodilation and retinal blood flow as measured in one single vein, in young healthy 
smokers. It should be noted that retinal diameter measurements and blood velocity 
measurements were not obtained simultaneously. Heitmar and co-workers (Heitmar et al. 
2010) reported no difference in retinal flicker response between smokers and non-smokers 
using retinal vessel analyser software, but found a significant difference when a different 
software (sequential and diameter response analysis) was used to analyse the diameter 
response.  
 
Studies which used 100% oxygen have found that retinal capillary and optic nerve head 
blood flow was reduced in young healthy smokers using scanning laser Doppler flowmeter 
(SLDF) (Langhans 1997). In contrast, another study reported that retinal vascular reactivity 
to 100% oxygen was more pronounced in smokers compared to non-smokers using laser 
Doppler velocimetry and retinal vessel analyzer (Wimpissinger 2005). Although these two 
studies used a similar magnitude of gas provocation (100% O2), the measuring techniques 
used were different. The results of these studies were attributed to the chronic effect of 
cigarette smoking. 
 
Morgado and co-workers (Morgado et al. 1994) reported retinal vascular reactivity to 60% 
O2 was significantly reduced immediately after smoking a cigarette compared to before 
smoking. Nevertheless their study did not compare the results with a non-smoking group. 
Robinson and co-workers (Robinson et al. 1985) reported increase in macular leukocyte 




mentioned above, neither COHb level in blood nor breath carbon monoxide level was 
measured in smokers. A small pilot data from present study showed a reducing trend in 
retinal vascular reactivity in response to normoxic hypercapnia 30 minutes after smoking 
compared to before smoking, but the results were not conclusive due to a small sample 
size. The carbon monoxide level measured before and after smoking was significantly 
different. Though the cut-off level to differentiate non-smoking and smoking status seem to 
vary between studies (Javors et al. 2005; Deveci et al. 2004), the present study has set a 
cut-off of 2ppm for non-smokers and 6ppm for smokers. Previous studies have reported 
that CO concentration in alveolar breath was found to be highly correlated with blood 
carboxyhaemoglobin levels (Wald et al. 1981).  
 
Carbon monoxide and nicotine are two major constituents of cigarette smoke. CO has 
approximately 200-250 times greater affinity to haemoglobin than oxygen. The presence of 
carboxyhaemoglobin (CO-Hb) reduces the oxygen carrying capacity of the erythrocytes. 
The CO-Hb dissociates very slowly in the blood due to the tight bonding of CO to 
haemoglobin, thus having a half-life of approximately 3-4 hours (Ernst and Zibrak 1998). 
Nicotine on the other hand, initiates catecholamine release through the activation of the 
sympathetic nervous system resulting in increased heart rate, blood pressure, and 
vasoconstriction (Benowitz 1991). 
 
Our study concludes that hypercapnia induced vasodilation is reduced in smokers. The 
enzyme nitric oxide synthase (eNOS) found in the vascular endothelium produces nitric 




the iron atom of heme in guanylate cyclase and thereby increases intracellular cyclic 
guanosine monophosphate levels, in turn leading to a decrease in intracellular calcium 
levels and hence vasorelaxation. Inhibition of eNOS activity has been shown to result in 
impaired hypercapnia induced vasodilation (Schmetterer and Polak 2001). Studies report 
that cigarette smoking impairs eNOS activity, thereby reducing the bio availability of nitric 
oxide resulting in impaired endothelial-dependent relaxation (Powell 1998). 
 
This study is the first to investigate retinal vascular reactivity in response to normoxic 
hypercapnia using CLBF and Doppler SDOCT in smokers. Previous studies have not 
simultaneously attained blood velocity and diameter measurements in smokers. Moreover, 
the hypercapnic gas provocation utilized in this study was also different from other studies.  
 
The limitations of the current study in terms of blood flow measurement technique is that, 
the Doppler signal strength achieved for retinal vessels using Optovue RTvue, was not 
consistent during different breathing conditions (baseline, normoxic hypercapnia and 
recovery) resulting in inconsistency when assigning a confidence score based on Doppler 
signal strength. Another limitation in comparing retinal vascular reactivity before (Session 
1) and after (Session 2) smoking is that a few subjects felt too fatigued to sit for session 2, 
for the same reason most of them exhibited difficulties in fixating during image 
acquisition. Therefore out of six CLBF measurements only three good quality 





In conclusion, this study used a novel gas provocation technique to investigate the retinal 
vascular reactivity in smokers and non-smokers using CLBF and Doppler SD-OCT. 
Cigarrete smoking reduced retinal vascular reactivity in smokers, however most of the 
smokers in the present study were light smokers (approximately 15 cig/day), whether 
heavy smokers (>25 cig/day) would exhibit a different response to hypercapnia induced 


















A growing body of evidence suggests that retinal blood flow measurement may play a role 
in the better understanding of major retinal diseases including glaucoma, diabetic 
retinopathy and age related macular degeneration (AMD) (Cuypers et al. 2000; Logan et al. 
2004). Various blood flow techniques exist as explained in chapter 1. However, almost all 
of them have limitations. Laser Doppler velocimetry is limited to only blood velocity 
measurement (Riva and Feke 1981). Colour Doppler imaging enables only the 
measurement of blood velocity, thus retinal blood flow measurement is not possible 
(Baxter and Williamson 1995; Harris et al. 2003). Similarly, the blue field entoptic 
technique can only measure the density and velocity of moving leukocytes in the macular 
capillaries, providing information only on blood flow in macular area. In addition, there is 
lot of subjectivity involved in this technique, and the reproducibility remains poor (Yap 
and Brown 1994). 
 
In contrast to the above mentioned techniques, the canon laser blood flowmeter (CLBF) 
simultaneously measures vessel diameter as well as blood velocity from major retinal 
arterioles and venules. The retinal blood flow measurement achieved using CLBF has 
proven to be repeatable and reproducible (Kida et al. 2002; Guan et al. 2003; Rose and 
Hudson 2007; Yoshida et al. 2003). The CLBF measures retinal blood flow from a single 
retinal vessel at a time. Achieving total retinal blood flow using CLBF is quite tedious, 






Recently, Doppler SD-OCT has evolved to be a promising tool in terms of achieving 
retinal blood flow measurement with minimum acquisition time and optimum consistency 
(Wang et al. 2009; Wang et al. 2007; Wang et al. 2008). Semi-automated software 
(DOCTORC) enables the calculation of TRBF measurement from the blood velocity and 
vessel cross-sectional area measurements. The cross-sectional areas and position of the 
vessels within the B-scan OCT images are refined by a human grader. The present study 
found optimum reproducibility among trained graders for TRBF and venous area 
measurements. However, a novice grader showed a learning effect in venous area 
measurements which might possibly influence TRBF measurements.  
 
Wang and co-workers (Wang et al. 2008) reported variability of 10.5% in a sample of ten 
subjects using Doppler SD-OCT. In the current study, the overall variability of TRBF and 
venous area measurements between sessions within a trained grader were 20.90% and 
17.64% respectively. The COV reported in our study was higher compared to those values 
reported by Wang and co-workers (Wang et al. 2008). It needs to be emphasized here that, 
in the present study, same subject datasets were graded twice by a trained grader, so the 
variability might be more appropriately attributed to the grading technique itself. In order 
to improve the image grading protocol, efforts are being taken to obtain automatic retinal 
blood vessel parameter calculations by modifying the scan protocol (Wehbe et al. 2007). 
 
In chapter 4, retinal vascular reactivity was investigated using CLBF and Doppler SD-OCT 
in a group of young healthy smokers and non-smokers. This study is the first to measure 




in smokers. Studies which used flicker stimulation to assess vascular reactivity remain 
controversial. They reported smokers to show reduced flicker induced vasodilation 
(Garhöfer et al. 2011), whereas others have reported that retinal vasodilation to flicker 
stimuli is unaffected in smokers (Cubbidge et al. 2012). Garhofer and co-workers 
(Garhöfer et al. 2011) reported that retinal arterioles and venules showed varying response 
to flicker induced vasodilation in smokers. Retinal arterioles showed a reduced flicker 
response, whereas retinal veins only showed a tendency to reduce.  
 
Studies which used gas provocation techniques coupled with blood flow measurement 
techniques to analyze vascular reactivity and blood flow changes in smokers are also 
equivocal. The retinal flow was reported to be reduced by 33% in response to 100% O2 in 
healthy non-smokers, compared to only 10% decrease in smokers, which indicates 
impaired hyperoxia induced vasoconstriction (Langhans et al. 1997).  Wimpissinger and 
co-workers (Wimpissinger et al. 2004) reported 10 minutes of breathing carbogen (95% O2 
& 5%CO2) significantly increased choroidal blood flow in non-smokers by +8.0%, 
whereas smokers responded significantly less to carbogen (-5.7%). The study also reported 
that retinal vessel diameter decreased in response to carbogen to a similar degree in both 
group. 
 
Only a few studies have reported the effect of cigarette smoking on CO2 induced 
cerebrovascular reactivity in humans. Smoking decreased the cerebral blood flow velocity 




contrast, a few studies have reported increased basal cerebral flow along with a decreased 
cerebral vascular resistance in smokers (Wennmalm 1982; Skinhoj et al. 1973).  
 
The possibility of contradictory results of smoking from different retinal and cerebral 
studies might be due to the difference in measurement technique, magnitude of gas 
provocation, different types of flicker stimuli, and different vascular bed studied. Though 
results from the present study could not be directly comparable to the above mentioned 
studies, we report reduced retinal vascular reactivity (especially diameter and flow 
response) to normoxic hypercapnia in young healthy smokers compared to non-smokers. 
 
The acute effect of smoking (30 minute after smoking) on retinal blood flow and vascular 
reactivity in a small group of smokers was also analyzed. Tamaki and co-workers (Tamaki 
et al. 2000) reported that, smoking had little effect on optic nerve head blood velocity in 
light smokers, compared to a more pronounced effect in heavy smokers, using laser 
speckle method. In their study blood pressure and pulse rate were significantly elevated 
from baseline until 20 minutes post smoking, after which the values dropped down to 
baseline levels. Robinson and co-workers (Robinson and Riva 1986) reported an acute 
increase in macular blood flow by 12% when measured within 30 minutes of smoking. 
Morgado and co-workers (Morgado et al. 1994) reported retinal vascular reactivity 
response to 60% O2 before and 10 minutes after smoking; before smoking velocity, vessel 
diameter and retinal blood flow reduced by -19%, -5.8% and -27.9% respectively. After 
smoking, velocity, diameter and flow changed by +1.4%, -5.3% and -9.6% respectively. 




In contrast to these studies, our pilot data does not show significant differences before and 
after smoking for retinal vascular reactivity and blood flow. Pulse rate and respiration rate 
was significantly high in just one of the sessions compared to before smoking. No systemic 
or gas parameter showed significant differences before and after smoking. This could be 
due to the following reasons: The small sample size; that both chronic (session 1) and acute 
(session 2) sessions were scheduled on the same day which made the subjects fatigue 
during session 2; the acute effect of smoking was measured 30 minutes after smoking; and 
that there were different levels of nicotine absorption among smokers. The arterial 
concentration of nicotine was shown to reach its peak within 10 minutes after smoking, 
after which the level drops down gradually (Armitage et al. 1975). For this reason, any 
acute effect of smoking on retinal vascular reactivity should have been measured 
immediately after smoking. Future studies will address these potential limitations by 
modifying the study protocol. 
 
In summary, results from this study indicate reduced retinal vascular reactivity to normoxic 
hypercapnia in young healthy smokers. A standardized and stable computer-controlled gas 
blender was used to provoke normoxic hypercapnia in all subjects. Total retinal blood flow 
and venous area measurements showed only a reducing trend in terms of retinal vascular 
reactivity; however retinal arteriolar diameter and flow response was significantly reduced 
to normoxic hypercapnia in smokers. The exact reason behind the impaired vasodilation to 
hypercapnic gas provocation remains unclear. Among other endothelial derived relaxing 
factors, nitric oxide is thought to play a key role in mediating hypercapnia induced 




cigarette smoking is capable of inducing morphological alterations to the vascular 
endothelium (Pittilo et al. 1984), and also alters the production of endothelial derived 
constricting and dilating factors (Zhang et al. 2001; Powell 1998; Celermajer et al. 1996). 
Whether or not reduced retinal vascular reactivity reported in smokers reflects impaired 
endothelial function remains ambiguous.  
 
5.1 Future directions 
The novel gas provocation technique utilised in this study enabled a comprehensive 
assessment of retinal vascular reactivity changes in young healthy smokers. Smokers 
showed reduced response to normoxic hypercapnia compared to healthy non-smokers. 
Impaired endothelial function, decreased nitric oxide bioavailability and reduced eNOS 
activity are reported to be the reason for altered vascular reactivity and blood flow in 
smokers (Zhang et al. 2001; Powell 1998; Celermajer et al. 1996). The results from various 
retinal vascular reactivity studies on smokers remain equivocal. Therefore future work on 
smokers needs to quantitate systemic level of cyclic glucose monophosphate (cGMP), a 
biomarker for endothelial function to provide more information on vascular regulation in 
smokers.  
 
A vast majority of studies have elucidated a causal relationship between cigarette smoking 
and ARMD (Thornton et al. 2005; Cheng et al. 2000; Klein et al. 1993; Vingerling et al. 
1996; Smith et al. 1996). Therefore in future, it would be interesting to continue the present 
work in ARMD patients (smokers and non-smokers) compared to age-matched non-




saturation and metabolic status of retina (Harris et al. 2003; Harris et al. 2008). Future 
study in ARMD patients would include retinal vascular reactivity and blood flow changes 
to normoxic hypercapnia, as well as assessment of retinal oxygen saturation using retinal 
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